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ABSTRACT
Antibacterial Hydrogel Coatings Derived from Novel Chemically Responsive Vesicles
Emily Mobley

In order for a drug, or any material used for the purpose of eliciting a change in an
organisms’ physical or chemical state, to be effective it must reach the intended target intact
and for a sustained rate over time. Drug delivery systems encapsulate a drug to protect it
from degradation, prevent side reactions, increase solubility, improve accumulation rates
at target sites, and release drugs at a controlled rate. Controlled and sustained release of
drugs is achieved by degradation of the carrier triggered by breaking dynamic chemical
bonds caused by changes in the chemical environment such as pH or redox conditions.
Slow, first order kinetic release of drugs increase therapeutic efficacy while also reducing
side effects and other cytotoxicity issues.
Up and coming drug delivery systems include hydrogels and nanocarriers such as
vesicles. Hydrogel drug delivery systems are unique three-dimensional networks of
crosslinked hydrophilic polymers that contain anywhere from 50-90 wt% of water. Drugs
can be loaded via encapsulation during the gelation process or may be covalently bound to
the polymer backbone before gelation. Amphiphilic molecules or polymers that selfassemble in aqueous solutions to form supramolecular nanostructures, such as vesicles, can
encapsulate hydrophilic drugs in the aqueous interior or hydrophobic drugs in the lipophilic
bilayer membrane.
This study seeks to embed vesicles into a hydrogel to create a hybrid drug delivery
system which may be applied as a coating to medical devices to prevent bacterial adhesion
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and growth, injected directly to a target site, or as an additive for wound dressings. This
hybrid system mitigates burst release from the hydrogel, as well as stabilizes the vesicles
to afford a longer shelf life. Vesicles are prepared from a novel supramolecular amphiphile
composed of thio-alkyl modified 𝛽-cyclodextrin as a macrocyclic host, and an adamantyldithiopropionic acid modified poly(ethylene glycol) as a linear guest. This host-guest
system forms inclusion complexes that self-assemble to bilayered vesicles, which may
encapsulate a payload, in aqueous solutions. These vesicles serve as three-dimensional
multivalent junctions to form a hydrogel, which may encapsulate a second payload,
through a dynamic disulfide exchange crosslinking reaction. This novel drug delivery
system will be capable of dual and selective release of two different encapsulated payloads.
A pH sensitive acid labile bond embedded in the crosslinker will cleave under acidic
conditions to release the payload enclosed in the hydrogel matrix, while a disulfide bond
embedded in the supramolecular amphiphile of the free vesicle can be cleaved in the
presence of naturally occurring antioxidant glutathione, GSH, to release the second
payload.
It has been discovered that vesicles efficaciously form, can encapsulate a payload, and
are stable for several weeks, up to a month. Vesicle stability is examined in the presence
of both intracellular and extracellular concentrations of GSH, and it is found that vesicles
are more stable in extracellular concentrations of GSH. Crosslinking of vesicles is
attempted at several molecular weights of linear thiol terminated poly(ethylene glycol)
crosslinker, concentrations ratios of crosslinker: vesicle, pHs, and temperatures. It can be
concluded that the crosslinking density with the linear crosslinker is not high enough to
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form a hydrogel. Future studies will include 4-arm crosslinkers which are predicted to
increase the number of crosslinking points and hence the crosslinking density.
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1. INTRODUCTION
1.1 Antibacterial Coatings
Polymeric coatings are an essential class of materials commonly used for
substrate protection and/or functionalization, as well as aesthetics and other
specialty functions. Types of coatings can range from clear to opaque, solvent to
water to powder based, thermoplastic or thermoset, ambient to radiation cured,
organic to inorganic, etc., and cover an expansive base of applications such as
architectural paints and lacquers.1 The complex science behind creating a
successful coating depends on the material’s end use goal. However, within this
diverse range of possible end products lies several commonalities as demonstrated
in Figure 1.1
Raw Materials

Disposal

Formulation

Service Life

Storage

Drying/Curing

Application

Figure 1: The process of coating formulation to application and disposal, all of which are
recurring elements in all coatings’ life cycles

1

There are numerous sub-classifications of coatings, among which is
antibacterial coatings. Antibacterial coatings are becoming increasingly more
significant across a wide range of industries, particularly within biotechnology and
medicine.2-7 Of the many challenges this industry faces when creating appropriate
coating materials, biocompatibility and stability of biomaterials it of utmost
importance for the material to attain long term use and effectiveness in order to
protect the substrate and/or provide other functions.2,5,6 Additionally, it is
imperative that these materials also provide a certain level of antibacterial character
in order to prevent the proliferation of bacterial infections amongst the fields of
biotechnology and medicine. Bacterial related infections are currently the 6th
leading cause of death in the world, with this rate being substantially higher in
underdeveloped countries.5 These infections are not only threatening from a health
perspective but also from an economic perspective. Health wise, materials such as
food processing equipment, medical devices, and implants are highly susceptible
to bacterial infection and cause health deficits to the population; whereas
economically, bacteria colonizing on industrial settings like pipelines, water
treatment plants, ship hulls, etc. contribute to vast rates of decreased efficiency and
increased operational costs for these essential industries.6 The root cause of these
issues can be traced back to bacterial adhesion on surfaces, which is why
antibacterial coatings have become paramount in research efforts.
In terms of treating all types of bacteria-surface related infections,
antibiotics have been widely used since the discovery of penicillin in 1928, and
have proven to be highly effective in expelling infections caused by the growth of
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pathogenic bacteria.8 Public health efforts based on expanding antibacterial
technology over time have significantly improved the quality of life across the
globe by suppressing many previously problematic pathogenic bacteria related
infections. Still, millions of people die annually as a result of these infections
because of the rise of multi drug resistant microorganisms.2 This is suspected to be
a direct result of using antibiotics to kill bacteria, and, unfortunately, our ability to
produce new antibiotics is currently vastly outpaced by these microorganisms’
abilities to evolve and give rise to new resistant species.2,5,9 Additionally, antibiotics
are also subject to poor solubility, cytotoxicity, and environmental toxicity at high
concentrations when used in isolation, all of which become especially problematic
for biotechnology, medical, and environmental industries.2,5,6,9 Current methods to
mitigate these issues involve the development of efficient drug delivery systems
that reduce the risk of bacterial resistance, as well as regulating concentrations of
drug agents to avoid both cyto- and environmental toxicity.2,5,6 Additionally, these
methods also use a variety of different materials aside from traditional antibiotics,
each of which has its own limitations and efficacy. Among these alternatives,
include nanoparticles of metal ions, natural extracts such as chitosan and seaweed,
antimicrobial peptides and enzymes, quaternary ammonium compounds, polymers,
and superhydrophobic materials.6 Ranking these different materials for coating
strategies in terms of effectiveness is considered largely impossible because they
are so dependent on specific clinical applications, which may vary in the need for
short versus long term use, bactericidal activity, application site, etc.
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Nonetheless, each of these surface coating strategies, regardless of material,
is largely focused on surface modification to either prevent bacterial adherence,
kill bacteria on contact with the surface, or release a drug agent to kill the bacteria
as it approaches the surface, as demonstrated by Figure 2.6.10,11

Figure 2: Three main types of antibacterial coatings being developed to prevent bacteria
colonizing surfaces and subsequent infections; I. Anti-Adhering Coating- which prevents
bacterial growth on surfaces, II. Contact Kill Coating- which kills bacteria that come in
contact with surfaces, III. Antimicrobial Substance Release Coating- which kills bacteria
that come into contact with surfaces by a stimuli responsive mechanism

Herein, in order to design effective antibacterial coatings within these categories, it
becomes important to investigate the mechanisms behind bacterial adhesion to
surfaces. Bacteria-surface interactions trigger certain changes in the expression of
genes that influence cell morphology and behavior, including those necessary for
surface mobility and attachment.10 This ability of bacteria to adhere to surfaces is a
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beneficial evolutionary trait that allows them to grow and proliferate while being
protected from shear and mechanical damages.10,12 While the phenotypes of this
evolutionary advantage have been studied and are well known, the underlying
mechanisms that bacteria use for sensing and responding to surfaces are not.
Current research has identified bacterial adherence to occur in two
consecutive phases; one that occurs rapidly and is easily reversible, and another
that occurs over several hours and is irreversible.10-13 The first reversible “physical”
phase is dependent on hydrodynamic and electrostatic interactions between the
bacteria and the surface, wherein the adhesive force between them increases
rapidly. The second irreversible “molecular” phase depends on non-covalent
interactions between the hydrophobic region of the bacterial cell wall with the
surface, and involves several proteins secreted to the surface by bacteria. While the
exact molecular mechanisms of these phases are not well understood, we do know
that they are heavily influenced by the laws of thermodynamics, wherein bacteria
work to minimize surface energy. Bacterial cells preferentially attach to
hydrophillic materials (which have high surface energy) when the surface energy
of the bacterium is larger than that of the liquid surface in which they are suspended,
but when the surface energy of the bacterium is lower than that of the liquid surface
in which they are suspended bacterial cells preferentially attach to hydrophobic
materials (which have low surface energy).10 This is why bacteria are able to adhere
to such a wide variety of surface types of varying hydrophilicity including glass,
aluminium, stainless steel, teflon and other fluorinated materials, organic polymers,
etc. Even with resistant surfaces, bacteria are able to trigger several mophological

5

changes, such as depositing layers of proteins, to make the surface more favorable
for adhesion.10-13 This creates a large challenge for antibacterial surfaces because it
requires precise control over surface chemistry, strucutral properties, and the
environment of a given surface.
To make matters worse, once bacteria are able to successfully adhere to a
surface, they begin to synthesize a hydrated matrix of extracellular polymeric
substances to form a biofilm, which, once formed, is exponentially more difficult
to treat as it is highly robust and dynamic in nature.10-13 Biofilm formation is a
multistep process, as demonstrated in Figure 3, and depends on several factors
including type of bacteria, type of surface, environmental conditions, and flow
conditions.11 Because biofilms are so ubiquitous in nature, it may not be possible
to eliminate them from surfaces, especially because they act as a highly effective
barrier from any external defenses. Specifically, biofilms act to reduce the net
negative charge of bacterial cells to enhance the stability of the membrane, and also
contain many dormant persister cells that are highly tolerant to any antibacterial
treatment and constantly upregulate specific antibiotic resistant genes within these
cells.10 In the medical field, bacterial infection and resultant biofilm formation on
medical devices or implants can begin pre- peri- or post-operatively, and may occur
over the course of several years, as bacteria are known to be able to maintain a low
metabolic rate for long periods of time.12
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Figure 3: Generalized multistep process of biofilm formation; I. Bacteria Attachment to
Surface, II. Bacteria Mono-film Formation, III. Bacteria Cell-Cell Adhesion and
Proliferation, IV. Mature Biofilm, V. Biofilm Detachment

In this case, there is a direct competition between host eukaryotic cells and bacterial
cells on the surface which depends on several factors- physiochemical properties
of the surface, bacterial concentration and virulence, and eukaryotic cell
properties.12 In short, there is a molecular race occurring between eukaryotic and
bacterial cells for integration upon indwelling surfaces of such devices and implants
which invade surrounding epithelial and mucosal barriers. Common devices that
are prone to these types of infections include all types of catheters, fracture fixation
devices, dental implants, prosthetics, vascular grafts, pacemakers, mammary
implants, mechanical heart valves, and even wound dressings.13 Implanting devices
innately impairs host defense mechanisms, so infections may rapidly become
7

chronic, wherein the only treatment available is to remove the associated device
because destroying biofilms involves such high levels of antibacterial agents that it
would cause cytotoxic effects to the host.3,4,7,13 This is a financial drain for the
medical and biotechnology industries, as devices and implants are not able to
achieve their full service life before being replaced, as well as a health detriment
to hosts as the infection may still persist after device removal.
Combatting these highly evolved genetic advantages of microorganisms is
no small task and must focus on specific bacterial characteristics such as their
mechanisms of adaptiveness to different environments. Optimizing thin film
antibiotic coatings is now largely considered essential, as bulk material properties
have more or less already been optimized.5 The advantage of thin film coatings is
that they are able to impart certain characteristics and functionalities to the surface
without effecting those of the bulk material.1 Relevant surface modifications with
antibacterial coatings to prevent initial attachment of bacteria and subsequent
biofilm formation may include altering the chemical composition of surfaces,
mainly hydrophilicity and charge, as well as roughness and porosity, in order to
achieve the desired bactericidal effect once applied to a given surface.11-13 All the
while, we must also take into consideration avoiding any inflammatory responses
from the host immune system, specificity against cytotoxicity of eukaryotic cells,
biocompatibility, solubility, long term stability and environmental sustainability of
materials and processes to make them, antibiotic resistance, over/under dosing,
etc.2-13
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1.1.1 Hydrogel Coatings
One such promising material for highly effective thin film antibacterial
coatings involves the use of polymeric hydrogels. Hydrogels are three-dimensional
polymer networks often crosslinked by either physical interactions, ie. chain
entanglements or polymer microstructure interactions, or chemical interactions such
as intermolecular forces (IMFs) or covalent bonds and are distinct due to their unique
physical properties.2 One important division to make when discussing hydrogels is
the difference between hydrogels and gels. Although chemically similar, the two
materials are physically different in that hydrogels will swell and absorb solvent
while maintaining their 3D crosslinking network, whereas a gel is already swollen
to equilibrium when formed and will dissolve in solvent.14 The former is more
advantageous for coating applications because they are able to continually establish
equilibrium in response to varying solvent environments.
Furthermore, as evident by Figure 4, there are truly an innumerable amount
of polymer combinations that may form a hydrogel matrix. Therefore, it is important
to consider specific end use goals when selecting raw materials for any hydrogel
coating system; in this case, the design of a biocompatible and efficient therapeutic
delivery system for broad spectrum antibacterial activity.3 Common applications for
antibacterial hydrogels include a wide range of equipment used in the medical and
biotechnology industries that suffer from bacterial infections, as previously
mentioned in section 1.1.
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Figure 4: Generalized polymer chain entanglements/crosslinking that form thin film
hydrogels, wherein mesh size may vary from micro- to nanoscale

Hydrogels inherently have varying degrees of porosity that allow them to
absorb water and/or other solvents at hundreds to thousands of times their own
volume, which lends itself to high swelling capacity, oxygen permeability,
biocompatibility, and structural diversity.2,6 These traits, among many others, make
hydrogels highly dynamic and easily customizable materials, and has subsequently
caused them to be the focus of many research efforts in the field of developing
antibacterial coatings.
In the case of antibacterial coatings in the biotechnology and medical
industries, hydrophilicity is of the upmost important physical properties, as it allows
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the material to be biocompatible under physiological conditions.2,3,4 Among
previously mentioned physical properties, hydrogels also have a high surface area
to volume ratio, which make them controllable structures than can easily mimic
natural tissue, which is highly advantageous in terms of compatibility with
biological systems.6 When coupling this property with an adjustable mesh size,
hydrogels have also been demonstrated to have the ability to attain controlled and
prolonged release of encapsulated materials, local administration, and stimuli
responsivity to certain environmental triggers such as pH, temperature, oxidationreduction reactions, and concentrations of particular chemical species.15 This stimuli
responsiveness can be customized towards a particular end use goal by making
various chemical and/or physical modifications to the underlying crosslinked
polymer network structure. In some cases, this responsiveness has allowed hydrogel
coatings to act as self-healing materials, which is highly desirable in terms of
attaining long service life and reducing raw materials costs in the long run.16
1.1.1.1 Hydrogel Coatings Preparation Methods
There are a variety of preparation methods for making hydrogel coatings
with antibacterial activity; each with its own strengths and limitations. These
methods can be classified into a few categories which are as follows.2
•

Inorganic nanoparticle containing hydrogels

•

Antibacterial agent containing hydrogels

•

Hydrogels with inherent antibacterial capabilities

Inorganic nanoparticle containing hydrogels contain nanoparticles such as
metal ions and metal oxides (ex: silver, copper, gold, silica, zinc oxide, titanium
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dioxide, and nickel oxide), which have inherent antibacterial character and have
been demonstrated to maintain broad range antibacterial activity over long periods
of time while also reducing the likelihood of antibacterial resistant species arising.
Loading nanoparticles into a hydrogel matrix is a convenient and controllable
platform for biofunctionalized metal nanoparticles. Although the mechanism of
action isn’t entirely understood, it is hypothesized that these metal nanoparticles act
via attaching to the cell wall by electrostatic interactions and subsequently disrupting
the cell membrane of bacterial cells and/or generating reactive oxygen species to
induce oxidative stress by free radical formation.6 However, this mechanism for
antibacterial activity lacks specificity for bacterial cells, and consequently has
several negative impacts on eukaryotic genes as well. This is because reactive
oxygen species cause DNA damage, mitosis inhibition, and chromosomal instability
in healthy eukaryotic cells as well. Hence, when making hydrogel materials
embedded with metal nanoparticles, it is important to optimize biocompatibility by
achieving high spatial dispersion of nanoparticles within the hydrogel matrix to
avoid agglomeration, as well as overall compatibility in an organic environment, so
as to avoid any damage to healthy cells. This is because agglomeration of
nanoparticles in a hydrogel matrix can rapidly lead to overdosing and subsequent
cytotoxicity to the host eukaryotic cells. Similarly, incompatibility in an organic
environment renders the nanoparticles unstable, and subsequently unsuitable for use
in biological systems due to the toxicity risk of metal nanoparticles leaching out of
the hydrogel. Optimization of biocompatibility is most commonly achieved with a
layer by layer coating method, wherein the layers of the hydrogel coating alternate
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between containing metal nanoparticles and void of metal nanoparticles.4 This outer
layer is typically void of metal nanoparticles and acts as a shield to prevent
cytotoxicity while maintaining long term antibacterial activity. However, this
method does not entirely prevent damage to eukaryotic cells and therefore is not
suitable for some applications.
The second type of antibacterial hydrogels are antibacterial agent containing
hydrogels, wherein an “antibacterial agent” can be defined as any material that is
embedded within the hydrogel matrix for the purpose of eliciting antibacterial
activity. As previously mentioned in section 1.1 and visualized in Figure 5,
commonly used antibacterial agents are antibiotics, antibacterial peptides,
antibacterial enzymes, quaternary ammonium compounds, chitosan, and other
natural extracts.6 With any of these materials, and especially with conventional
antibiotics, it is imperative to minimize the development of antibiotic resistant
bacterial species arising by minimizing the concentration of antibacterial agents to
that which is able to be effectively bactericidal without inducing extra systemic
toxicity.
The advantage of using conventional antibiotics is that their properties are
well known and easy to apply in a medical setting, but the drawback is that of the
antibacterial agents, antibiotics are the most likely to lead to the development of
antibiotic resistant species. With antibacterial peptides, this is not an issue, as they
are already present in our immune systems which is advantageous because they are
biocompatible and do not show any direct toxicity effects on mammalian cells.6
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Figure 5: Different types of antibacterial agents with examples of structures

These compounds act by using their positive charges to associate with the negatively
charged bacterial cell wall and disrupt it. However, they are very similar to common
eukaryotic signaling peptides, so when tethered within a hydrogel matrix they have
been known to cause undesirable hemolytic effects. Antibacterial enzymes are
similar to antibacterial peptides in that they are largely considered non-toxic while
remaining bioactive.6 They are also commonly used in detergents, industrial
processes, and the food industry and are known to achieve a bactericidal effect in
hydrogel coatings by preventing bacterial adhesion due to enzymatic degradation of
14

molecules essential for bacterial functionality, or causing direct hydrolysis of the
bacterial cell wall. The disadvantage here is that retaining enzymatic activity is very
difficult, as the enzymes tend to become instable when immobilized within a
hydrogel matrix or on the surface of a coating. With quaternary ammonium
compounds, their bactericidal effectiveness is dependent on whether the positive
charge density of the coating is able to exceed the threshold of 1015 N+ cm-2 with an
alkyl chain length between 4-18.6 This is because the mechanism of action involves
the quaternary N atom’s attraction to the phospholipid head groups of the cell wall,
while the hydrophobic tail becomes incorporated into the cell membrane to lyses the
bacterial cell. These compounds are also, however, limited because they require a
certain degree of freedom to achieve antibacterial activity. In this case, this
conformational freedom can be attained by tethering the compound to the surface of
the hydrogel coating, rather than embedding it which may cause biological
instability. Finally, chitosan is a naturally derived material with inherent bactericidal
effects, and is also highly biocompatible and easily modifiable.6 The limitation with
this material is mainly that the bactericidal activity is low compared to other
antibacterial agents as it is highly dependent on the degree of chitosan acetylation.
However, a benefit of using slow release mechanisms from any type of antibacterial
agent containing hydrogels is that it tends to increase the effectiveness of the
antibacterial agent itself owing to targeted, minimal usage of materials.6
Both inorganic nanoparticle and antibacterial agent containing hydrogels
generally involve the encapsulation and release of materials from the hydrogel
matrix, which involves various chemical, physical, and biological triggering
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mechanisms. A general structure of a hydrogel coating containing an encapsulated
payload is demonstrated in Figure 6. Additionally, it should be noted that
encapsulated payloads also vary in loading methods and efficiency, which is highly
dependent on the compatibility of the specific polymers being used to form the initial
hydrogel matrix with the encapsulated materials. Most commonly, antibacterial
hydrogels are made using polyethylene glycol (PEG) or polysaccharides, because of
their biocompatibility features, and then coupled with any of the bactericidal
materials previously mentioned.

Figure 6: Generalized polymer chain entanglements/crosslinking that form
thin film hydrogels that are capable of loading various payloads within the
hydrogel matrix

The last type of antibacterial hydrogels are those that have inherent
antibacterial activity without the incorporation of other materials. Mainly, these
16

hydrogels are those that are comprised of polymers with either non-stimulated or
potential antibacterial activity. Here, non-stimulated polymers have inherent
structural components that lend themselves to bactericidal activity, whereas
potential polymers can be converted to become antibacterial under certain
conditions. One such common example of this is polymer brush surfaces attached to
the exterior of a hydrogel. In this case, polymers are used to prevent bacterial
adhesion by occupying majority of the external surface area to create an osmotically
driven steric barrier for bacterial adhesion.6 This acts as a passive mechanism to
avoid bacterial infections on surfaces. In order for this method to be effective in
terms of antiadhesive properties, the polymers need to be well hydrated, which is
why covalent or physisorption to the surface of thin film hydrogel coatings is so
advantageous- because hydrogels are able to hold more water without collapsing
than a polymer brush surface on its own.6 Polymer brushes on the surfaces of
hydrogels are, however, limited because they are unable to prevent biofilm
formation over long periods of time. For this reason, polymer brushes are often
combined with the loading antibacterial agents to the hydrogel matrix to increase
bactericidal efficacy over longer periods of time. Similarly, superhydrophobic
surfaces possess extraordinary antiadhesive properties, and hence are inherently
highly effective at preventing bacterial adhesion to surfaces.6 However, this method
is seldom successful in coupling with antibacterial hydrogels because it is inherently
incompatible with the hydrophilic nature of hydrogels, as well as any biological
system.
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Overall, the most widely utilized methods for preparing hydrogel coatings
for use in the biotechnology and medical industries involve combining multiple
types of antibacterial hydrogel coatings; mainly the incorporation of various
antibacterial agents, which may or may not be coupled with polymer brush surfaces
or layer by layer coating deposition including inorganic nanoparticles. However,
current research efforts are still needed to expand upon this technology as many
more developments are needed to achieve an effective and biocompatible
antibacterial hydrogel coating material for widespread application. The main
limitations currently are scaling up production of materials, long term stability, and
efficient use of biocompatible antibacterial agents that have broad spectrum
bactericidal activity without giving rise to new antibiotic resistant species or other
undesirable systemic side effects.
1.1.1.2 Hydrogel Coatings Characterization Methods
Antibacterial hydrogel coatings can be characterized for a variety of physical
properties such as swelling capacity, storage/loss modulus, elasticity, mesh size,
hydrophilicity, stability, responsivity, encapsulation ability, level of bactericidal
activity, biocompatibility, and cytotoxicity level. Some common instruments used
to determine these properties include scanning electron microscopy, transmission
electron microscopy, atomic force microscopy, x-ray photoelectron spectroscopy,
dynamic mechanical analysis, and rheology.7,14
Because hydrogels can be so structurally diverse depending on the raw
materials and preparation methods used, it is important to characterize the structure
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of the hydrogel including porosity, mesh size, and relative uniformity of the
hydrogel matrix.
Surface characterization is often accomplished with a combination of
microscopy methods. X-ray photoelectron microscopy is a method based on the
photoelectric effect, which describes what happens when electromagnetic radiation
hits a material, and measures both the chemical composition and state of the material
as well as any electronic properties. This is useful for determining the surface
composition and uniformity of hydrogel coatings.7 To obtain optical images of the
surface, scanning electron microscopy or transmission electron microscopy are often
used.14 Scanning electron microscopy acts by emitting beams of electrons to the
surface which interact with atoms to produce a topographical image of the surface
composition with a resolution down to a few nanometers. Transmission electron
microscopy has a much higher resolution due to a smaller de Broglie wavelength of
electrons transmitted through the sample. These images are useful for determining
the mesh size and porosity of the hydrogel matrix. Atomic force microscopy is
another common method that has excellent resolution, up to fractions of a
nanometer, which is more than a thousand times better than optical diffraction limit.
This method can produce topographical maps of the surface by scanning with a small
cantilever tip coupled with laser focusing. Results from these measurements are
useful for characterizing porosity and roughness of the hydrogel coating surface.
Other physical properties are often measured using rheology and dynamic
mechanical analysis. Because hydrogel coatings can absorb various solvents up to
about a thousand times their own volume, it is important to characterize the flow
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behavior of these materials. Rheology relates the relative stress and strain responses
of the material to various shearing to uncover any viscoelastic properties. This
measurement is useful because it yields information about for the storage and loss
modulus of the material, which tells how it will respond to various environmental
forces once applied to a surface. Similarly, dynamic mechanical analysis
measurements also characterize viscoelastic properties of the material. This method
applies a sinusoidal stress to the material and measures the corresponding strain that
occurs at various temperatures to yield a complex modulus. These measurements are
especially important when considering antibacterial hydrogels that are to be applied
in biological systems, as they will be constantly exposed to shear stress from
surrounding plasma and/or tissue, and must be able to remain stable in response.5
1.2 Drug Delivery Systems
When considering antibacterial hydrogel coatings as a functional material
for biological applications, it is important to recognize that this material innately
functions as a drug delivery system. Herein, a “drug” can be defined as any material
either encapsulated or inherent to the bulk material for the purpose of eliciting a
change in an organisms’ physical or chemical state once released to the target
environment.17 Examining the current progress and methods used in upcoming drug
delivery systems helps us to understand how a hydrogel coating can be customized
for a variety of biological applications to achieve a therapeutic effect.
One of the issues paramount to improving the therapeutic efficacy of drugs
is that the process of making new drugs is both time consuming and financially
draining. This is because each new drug molecule made must go through rigorous
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testing to get approved by the Food and Drug Administration (FDA) for
commercial use including discovery in vitro, clinical trials in vivo, further
development and optimization, and regulatory restrictions.17 Herein, the gap from
“in vitro” to “in vivo” studies is substantial. In vitro studies are typically used as a
proof of concept phase, but majority of drug candidates that make it past in vitro
studies will subsequently fail in vivo studies because there is an exponential
increase is systemic complexity when going from physiological mimetic conditions
to a true physiological system. Overall, the process of getting a new drug candidate
approved typically takes an average of a decade and can end up costing over $120
million dollars.17 Because of this largely impractical protocol for approving newly
developed drugs, majority of current research efforts have been focused instead on
creating better drug delivery systems to administer already approved drugs that may
have issues with absorption and general biocompatibility, site specific activity,
and/or systemic toxicity issues, etc. on their own.17,18 Perhaps the biggest issue with
drug delivery is the poor solubility of many pharmaceuticals. In fact, more than
40% of all currently approved drugs are nearly insoluble in water, which causes the
drugs to have very poor biocompatibility and distribution since in order for a drug
is to be properly absorbed, it must be in solution at the target site.19 These features
subsequently make hydrophobic drugs very problematic to deliver effectively
because biological systems exist in an aqueous environment, which makes it
difficult for the insoluble drug to diffuse into cell membranes, so higher
concentrations of drug are needed to achieve any effect.18 However, this often leads
to unwanted side effects and/or toxicity issues.18 Hence, some of the goals of new
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drug delivery technology is to mitigate the aforementioned barriers and deliver
drugs at a slow and controlled rate over time, with target specific release at the
appropriate dosage, without eliciting an immunogenic response, systemic toxicity,
or other harmful side effects.17,18,20
With any drug delivery system, there are two primary pathways in which
drugs may be delivered to the target site- passively, or actively.18 In passive drug
delivery, the carrier or drug itself will circulate freely until it reaches the desired
target site, which may be influenced by a variety of external factors such as pH or
temperature, and then release the drug based on affinity, binding, or stimuli
responsivity to the target site. In active drug delivery, specific chemical moieties
are incorporated onto the drug or drug carrier, such as peptides or antibodies, which
will target a specific site for expression and subsequent drug release. Each of these
delivery pathways is dependent on a slew of physiochemical and environmental
factors, which are quite different depending on the drug administration method.
Many drug administration methods are demonstrated by Figure 7, wherein each
method has its own pros and cons. Generally, oral administration is preferred
whenever possible because it has the highest levels of patient cooperativity and is
easy to follow. Transdermal, topical, and injection methods are also generally
preferable because they are relatively simple to administer and bypass the first pass
effect, wherein the concentration of a drug taken orally is greatly reduced by first
pass metabolism before it reaches systemic circulation.19,2121 This allows lower
concentrations of drugs to be administered, which is advantageous because less
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drug is needed to achieve the same effect. However, it is impractical to rank these
drug administration methods, as they are each used for specific purposes.

Figure 7: Routes of drug administration for all types of pharmaceuticals

Regardless of administration method, for drugs to be delivered and achieve
the desired therapeutic effect, they must have adequate bioavailability. This means
that the drug must have a substantial fraction of the initial dose that reaches
systemic circulation and eventually its target site. Bioavailability is influenced by
aqueous solubility levels, drug permeability to the target site, dissolution rate, first
23

pass metabolism, pre-systemic metabolism, and susceptibility to efflux
mechanisms that remove solutes from cells.19 Additionally, it is important to
maximize the therapeutic index of drugs. This parameter compares the amount of
drug that elicits a therapeutic effect to that which causes toxicity.22 Therefore, the
higher the therapeutic index, the safer the drug. Although increasing bioavailability
and therapeutic indices of drugs are the main overarching goals of new drug
delivery technology, there are a variety of different systems emerging which
attempt to mitigate a range of issues related to drug delivery.
1.2.1 Types of Drug Delivery Systems
One aspect that majority of new drug delivery systems have in common is
that they implement some sort of external carrier that serves to both protect the drug
from the surrounding environment, and efficaciously deliver it to its target site.20,22
Previous research in the field has established that macromolecular carriers and/or
conjugates for drug molecules are highly effective tools for delivering drugs in a
safe and controlled manner to their target sites in vivo. The continuing evolution of
these carrier systems offers several desirable benefits to improve drug delivery such
as the simplification of drug administration schemes, reducing toxicity levels of
drugs in circulation, and overall improving therapeutic indices and disease
outcomes.20 There are several requirements that must be met in order for a carrier
to be successful.20 First and foremost, the carrier must be able to encapsulate a
sufficient amount of hydrophobic and/or hydrophilic drug and remain in circulation
in a physiological medium with tunable leakage. Additionally, the carrier must be
able to target, accumulate, and distribute the drug at the desired site, as well as
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increase bioavailability and biocompatibility of the drug. The carrier may
accomplish this by solubilizing the drug, minimizing drug interactions with nontarget cells, such as endocytosis or absorption, and minimizing elimination or
degradation of the drug before it reaches its desired target site. Finally, the carrier
must not illicit any immunogenic responses from the host immune system, be safe
at all stages of drug delivery (ie. before, during, and after drug release), and must
have a cost-effective synthetic pathway with ease of scale up.

Figure 8: The most significant nanoscale drug carriers explored in current research;
micelles, telo-dendrimers, inorganic nanoparticles, hydrogels, linear polymers,
quantum dots, dendrimers, and liposomes
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Specific carrier targeting mechanisms will be reviewed in a later section
(ie.1.2.2), and here we will take a closer look at the different types of carriers
currently in development, as demonstrated in Figure 8. Particularly, we will be
looking at nanoscale drug carriers, as they have been shown to have significantly
better uptake by cells than larger particles.
As the archetype of nanoscale drug delivery platforms, liposomes were the
first to be approved for clinical use in 1995 (Doxil ®, delivers doxorubicin for the
treatment of various cancers) and have since gained in popularity and technological
developments.23 Liposomes are formed by the self-assembly of amphiphiles, and
consist of a bilayer membrane that is similar to that of biological cells, which makes
liposomes suitable for mimicking fundamental cellular functions such as motility
and shape changes in response to the extracellular environment.20,23 This biological
mimic behavior allows liposomes to go largely undetected by the host immune
system as a foreign body, which is highly advantageous for a drug carrier as it
prevents immunogenic responses. However, most liposomes in development are
phospholipid based and tend to have poor stability and rapid clearance due to strong
interactions with circulating proteins in blood plasma.20 For this reason, it is
common to use poly(ethylene glycol) (PEG) and its derivatives, as either part of the
liposome itself or grafted to the exterior of the membrane in some way, to further
impart stealth properties on the liposomal carriers.24 This is because PEG is soluble
in both aqueous and organic media, is non-ionic, and is subsequently known to
function as an inert polymer to improve circulation time and biocompatibility of
liposomal drug carriers.20,23,24
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Figure 9: A closer look at general the structure of liposomes

Taking a closer look at the general structure of liposomes in Figure 9, we
see multiple sites for drug encapsulation (ie. within the lipophilic intramembrane,
or within the hydrophilic interior cavity). This is highly advantageous because it
allows liposomes to encapsulate both hydrophobic and hydrophilic drug molecules,
which also makes for better cell penetration for hydrophilic drugs and improved
solubility for hydrophobic drugs.20 Another feature of these types of carriers is that
the physiochemical properties are easily customizable for a variety of target sites
and improving biodistribution, circulation times, loading capacity, etc.20,23 Being
such, there are several different classifications of liposomes. Liposomes may be
classified according to lamellarity (ie. uni, bi, or multi), size (ie. small <100nm,
intermediate 100-250nm, large >250nm, or giant >1𝜇m), surface charge (ie.
anionic, nonionic, or cationic), etc.20 Typically, the type of preparation method will
have a large impact on these factors. For example, using the common thin film
hydration method on its own usually results in oligolamellar and polydisperse
liposomes, whereas coupling this method with extrusion as a purification method
will exclude larger aggregates and results in a more monodisperse, unilamellar
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liposome solution. Generally, monodisperse and unilamaller are preferred because
they tend to behave more uniformly and predictably, which is useful for creating
statistical models to predict how they will interact with eukaryotic cells.20
Furthermore, there have been several sub-classifications of liposomes for
improving various features such as transferosomes for improving elasticity,
ethosomes for improving skin cell penetration, pharmacosomes for improving the
delivery of poorly soluble drugs, niosomes, virosomes, nebulized, stimuli
responsive, and specific cell targeted liposomes.21,23 However, majority of these
modifications have largely been unsuccessful thus far due to a variety of factors
ranging from instability to difficulties with industrial production and storage, apart
from stimuli responsive and specific cell targeted liposomes, which will be further
discussed in section 1.2.2.
Another type of drug nanocarrier like liposomes are micelles. These are also
formed from the self-assembly of amphiphiles and hence also have both
hydrophobic and hydrophilic moieties capable of encapsulating both hydrophobic
and hydrophilic drugs.25 They are much smaller than liposomes, on the order of
approximately 1-10nm, which makes for improved cell penetration. However, these
carriers aren’t as successful as liposomes because they are much less stable in
physiological media and hence tend to suffer from early drug release and
degradation.20
Still, there are other polymeric nanocarriers such as dendrimers, telodendrimers, linear polymers, and hydrogels. Linear polymers are the most
simplistic model, and yet possess innumerable possibilities for chemical and
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physical modifications. These materials can be either natural or synthetic, and
typically function by forming either a drug-polymer conjugate colloid suspension
or the aforementioned nanostructures (ie. liposomes or micelles).20 Dendrimers, on
the other hand, are highly branched polymers made from either convergent or
divergent reaction schemes that generate several generations of branching. These
materials are globular in shape, well defined, monodisperse, and multivalent
structures with large surface area functionality capable of encapsulating a variety
of drug molecules at a high loading capacity for controlled delivery and enhanced
cell permeation which results in overall better distribution physiologically.20,21
Telo-dendrimers combine a linear polymer chain with a dendritic segment to
enhance the self-assembly and mobility properties of the linear polymer chain, with
the uniformity and multivalence of dendrimers.20 In theory, this system should
function ideally for controlled encapsulation and release of drug molecules, but
these materials are still in the very early stages of development so there are not
many successful examples to speak of yet.24 Conversely, polymeric hydrogels have
been widely explored for applications as nanocarriers in drug delivery technology.
As previously mentioned in section 1.1.1, hydrogels have numerous advantageous
and easily tunable physical, chemical, and mechanical properties which make them
ideal for interacting with biological systems. In fact, hydrogels are the closest
mimic to biological tissues of any of the current nanoscale drug delivery platforms.
This is because of their high water content and soft rubbery texture, which makes
for very low interfacial tension with surrounding tissues and subsequently a low
tendency to absorb proteins from blood and other bodily fluids.14,26,27 Possibly the
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most unique feature of hydrogels that make them ideal for drug delivery is that they
have been demonstrated to have self-regulating capabilities. Herein, the hydrogel
matrix has a seemingly elastic memory which allows it to respond to changing
metabolic states in the body by swelling, altering network structure, permeability,
and/or mechanical strength, and then alter their release profile accordingly before
returning to their original state.14 Hydrogels are also ideal for implantable localized
drug delivery, which maximizes therapeutic efficacy and minimizes side effects
when compared to systemic approaches.27 However, like other nanocarriers,
hydrogels have a few drawbacks which are limiting their clinical viability such as
a limited ability to load hydrophobic drugs, and burst release of drug molecules.26,27
Alternative to polymeric nanocarriers, there are also quantum dots and
inorganic nanoparticles. These systems deliver drugs by coupling drug-ligand
conjugates to the surface, and accumulate successively at the target site by an
external magnetic field, but it is important that they are combined with another
delivery system, as they suffer from chronic uncontrolled release and clearance on
their own.21
1.2.2 Stimuli Responsive Delivery Mechanisms
Considering the issues with current nanocarriers as drug delivery systems,
mainly burst release of drug molecules at sites other than the target site, rapid
physiological clearance, and general instability, it becomes clear that these
nanocarriers could benefit from stimuli responsive delivery mechanisms. Smart
materials, as they are often termed, are of increasing interest for a variety of
industries, including biotechnology and medicine, because they are able to receive,
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transmit, or process a stimulus and respond by producing a useful effect.14,26,28,29
There have been many research efforts made to try to understand stimuli responsive
mechanisms in biological systems so that we may create effective mimics of our
own. Polymer based systems (ie. liposomes, micelles, linear polymers, dendrimers,
telo-dendrimers, and hydrogels) are exceptional materials for this purpose as they
are able to be made at large scales with a wide range of functionalities and postsynthetic modifications, and can be processed into a variety of different forms.24,28

Figure 10: Various potential stimuli and responses for nanocarrier drug delivery
systems

Several potential stimulus and responses are demonstrated by Figure 10, but
not all of these are viable for physiological applications because once the
nanocarrier enters the body, it is limited in the amount of stimuli present. Those
that are of the most interest for these systems are pH and temperature, because
physiological systems consist of many different organs, organelles and other
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compartments that vary in both pH and temperature.28,.29 Specific organ and cell
targeting has been a dream of pharmaceutical companies ever since the industry
began, because when a drug is targeted to a specific site either by affinity, charge,
etc. it eliminates potentially harmful side effects and toxicity to the system as a
whole. Coupling this targeting with stimuli responsive controlled release
mechanisms furthers this beneficial effect and makes for even more specific drug
delivery pathways.
For example, cancer tissue and chronic wounds are known to have a lower
pH, which makes pH sensitive linkages a target that can be used to elicit a response
(ie. release of the drug molecule) from a nanocarrier. Incorporating acid sensitive
moieties, such as acid labile bonds, on any of the previously mentioned polymeric
materials is useful for triggering controlled release of a drug from nanocarriers at
an acidic target site as the change in pH will elicit a conformational and/or chemical
change in the nanocarrier which causes it to release the active drug.29 As another
example, glutathione, a natural antioxidant found in higher concentrations
intracellularly than extracellularly, is also a suitable trigger which elicits a dynamic
covalent reaction between its thiol group and any disulfide modified polymer on a
nanocarrier to produce a dynamic covalent reaction which could cause the
nanocarrier drug release at a sustained and controlled rate.29 Overall, these are just
a few examples, as there are a wide variety of potential stimuli that can be installed
onto nanocarriers, and there has been an abundance of research into this area that
has shown various methods to be successful in improving circulation times,
stability, and controlled and targeted delivery mechanisms for drug molecules.26-29
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Furthermore, researchers have also been able to combine different types of
nanocarriers together with stimuli responsive moieties installed, which highlights
how truly innumerable the possibilities are for customizing the properties of
nanocarriers for drug delivery.28
1.3 Supramolecular Chemistry
Another key factor amongst biological systems- supramolecular chemistry,
although somewhat recently a discrete field of interest for biologists, chemists, and
physicists, has been a fundamental aspect of life since its origin. This is because
supramolecular chemistry is the ubiquitous factor that controls many biological
functions such as signal transduction, membrane transport, enzymatic reactions,
binding antibodies to macrophages, cell-cell recognition, protein folding, etc.30-34.
Contrary to covalent bond formation to form molecules, supramolecular chemistry
takes advantage of non-covalent interactions to form molecules. Although noncovalent interactions are individually weak compared to covalent bonds, taken
collectively they are quite powerful.31 These non-covalent interactions include a
variety of intermolecular forces such as hydrogen bonding, dipole-dipole, van der
waals, electrostatic attraction, 𝜋- 𝜋 stacking, metal coordination, charge transfer,
etc.31,35-38 Nature provides us with one of the most prolific examples of
supramolecular chemistry in action- the deoxyribonucleic acid (DNA) double helix
structure. These polymeric strands are held together primarily through 𝜋- 𝜋
stacking and hydrogen bonding and are able to store, receive, and process vast
amounts of information all while being both responsive and adaptive to the external
environment.31,32 Structures, such as DNA, that are held together through non-
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covalent interactions are commonly called supramolecules. Supramolecules are
complex structures made up of many smaller building blocks held together very
precisely by non-covalent interactions.31 Studying biological building blocks such
as nucleic acids for DNA, proteins for protein folding, and lipids for cell
membranes that each create sophisticated hierarchical structures that are held
together by non-covalent interactions helps researchers understand how they can
mimic this molecular recognition behavior synthetically. The first synthetic
supramolecules on record were crown ethers, for which the Nobel Prize in
Chemistry was awarded in 1987 to Lehn, Pederson, and Cram for their design and
development of cryptans, crown ethers, and cavitands, respectively.30,31 These
complex structures have many interactive properties and are easily customizable
for a variety of applications such as sensors, luminescence, gels, biological and cell
imaging probes, liquid crystals, etc.31 The possibilities are truly endless with these
dynamic materials, which makes them very attractive for research and development
across many fields of study.
Over the years since their synthetic journey began, supramolecules have
evolved to even more complex and larger architectures such as macromolecules,
multimetallic helicates, rotaxanes, coordination polymers, etc.31 Continuously
evolving and inspired by several biological systems and processes, supramolecular
chemistry primarily relies on the programmed self-organization of its building
blocks. This self-organization has been termed self-assembly, wherein the building
blocks spontaneously yet controllably organize themselves into complex and
sophisticated architectures, driven by non-covalent interactions.32 This type of non-
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covalent synthesis is superior to traditional covalent synthesis in that it is simplified,
the bonds form spontaneously without any harsh conditions or chemical reagents,
are reversible under thermodynamic equilibrium, conditions, and do not produce
any undesired side products.30,35 The bottom up assembly style allows for highly
specific control over properties of the resultant complex structure because it begins
with the simplest building blocks and as they bind together increase in complexity
which results in highly homogenous chemical assemblies with less defects and
better short- and long-range ordering.30 For example, stereo-control (ie. controlling
which stereoisomers are formed by a reaction) over covalent synthesis is difficult
but possible, whereas with non-covalent synthesis it is exponentially more difficult
in theory because bonds of the individual building blocks are kinetically labile and
are continuously breaking and reforming. However, in practice, stereo-control with
self-assembly is not an issue because of the amplification of chirality, wherein the
achiral building blocks seem to follow the chiral building blocks in their selfassembly pattern regardless of the relevant concentrations.30 Overall, self-assembly
of supramolecules requires precise control at the molecular level, which then
influences the macroscopic level and bulk material properties.
1.3.1 Amphiphiles as Building Blocks for Self-Assembly
Perhaps the most powerful self-assembly building blocks are amphiphiles,
which are also called surfactants (ie. surface active agents) interchangeably.
Amphiphiles are characteristic in that they contain both a hydrophobic and a
hydrophilic moiety, which may be linked together covalently or noncovalently.25,34-38 When they are linked non-covalently the amphiphile is then
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referred to as a supra-amphiphile. Regardless of how bonds are formed, there are a
variety of different types of amphiphiles which are classified based on structural
components. Topologies can range from any combination of hydrophilic “head”
groups and hydrophobic “tail” groups. For example, one hydrophilic head with one
hydrophobic tail, two tails one head, etc. Two unique topologies are termed
bolaform, in which two hydrophilic groups are covalently linked to a single
hydrophobic chain, and gemini, in which two different amphiphiles are linked at
their charged head groups.35
One property that makes these molecules particularly unique and powerful
tools for self-assembly and supramolecular chemistry is that when they are
suspended in water, the hydrophilic moiety prefers the aqueous phase, while the
hydrophobic moiety prefers an organic phase. Depending on the particular
amphiphile topology, self-assembly behaviors and subsequent physical properties
will differ because a different structure means different interactions in solution
which leads to different aggregations. Typically, amphiphiles will first form a
monolayer at air-water interfaces with the hydrophobic moiety facing the air and
the hydrophilic moiety facing the aqueous solution, but when the concentration of
amphiphile in solution is high enough they are driven to self-assemble based on the
repelling and coordinating forces between the hydrophobic and hydrophilic
moieties and the surrounding environment, as visualized in Figure 11.36
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Figure 11: Amphiphiles containing a hydrophobic and hydrophilic moiety may selfassemble into a variety of nanostructures in aqueous media including but not limited
to a) Micelle b) Bilayer c) Vesicle

This phenomenon is driven by the hydrophobic effect, and will occur at or above
the critical micelle concentration (CMC) (ie. the concentration at which
amphiphiles form micelles in solution). Further increasing the concentration of
amphiphile beyond this point will result in nanostructures of increasing complexity,
such as bilayers and vesicles.39
Herein, the hydrophobic effect can be defined as the tendency for
hydrophobic segments of molecules to exclude themselves from the surrounding
aqueous media by forming aggregates in solution where the hydrophobic segments
of amphiphiles interact with each other, while the hydrophilic segments interact
with the surrounding aqueous environment.40 The hydrophobic effect is a
thermodynamic phenomenon which is effected by both enthalpy and entropy, and
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is overall thermodynamically favorable and hence spontaneous. Although it may
seem counterintuitive at first, the hydrophobic effect is primarily driven by entropy,
except at high temperatures where enthalpy is the driving force.40-43 This is because
of the relationship between the free energy required for hydrophobic hydration and
the strength of the water mediated attraction between pairs of solute molecules.
When a hydrophobic molecule is dissolved in water, the water molecules form
highly ordered networks around the molecule. In order to minimize the surface area
exposed to the aqueous environment, the hydrophobic molecules will aggregate
with each other to exclude water and the water molecules involved in the highly
order network are then free and the entropy of the water increases. When compared
to the entropy loss of hydrophobic moieties creating ordered structures in solution,
this gain in entropy from freeing water molecules is orders of magnitude higher.42
Therefore, the entropy loss of forming ordered structures is significantly less in
magnitude than the entropy gained from the freeing of water molecules.40-43 Hence,
forming ordered nanostructures in aqueous environments is actually highly
entropically favorable. The hydrophobic effect is central to the self-assembly of
amphiphiles into highly ordered nanostructures, in which the function of the whole
is much greater than the sum of its parts.31
1.3.2 Inclusion Complexes with a Host-Guest Based System
One particularly unique class of supramolecular amphiphile non-covalent
assembly is driven by host-guest interactions, which refer to the forming of a
supramolecular amphiphile in which one component includes within the other, as
demonstrated by Figure 12.
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Figure 12: Inclusion complex formation reaction involves the combination of a
compatible host and guest molecule, which will then self-assemble

Typically, a small organic molecule will include within the hydrophobic cavity of
a macrocyclic host. The host and guest molecule can be functionalized with one
component possessing hydrophobic tail and the other functionalized with
hydrophilic moieties. Then, instead of covalently linking the hydrophilic and
hydrophobic portions of the molecules, a supramolecular amphiphile will
spontaneously self-assemble in aqueous solutions. This type of host- guest
chemistry is driven by the hydrophobic effect and favorable non-covalent
interactions. The combination of these forces can form a stable complex, which
may be comparable in strength to a covalent bond.35, 44 This non-covalent synthesis
forms an inclusion complex which, dependent on the degree of amphiphilicity, will
self-assemble into a variety of nanostructures in aqueous media. Herein, the
inclusion complex is typically formed by the evaporation of solvent to create a thin
film, and subsequent hydration of this film will give rise to self-assembly.39 The
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binding ability of the host-guest can be mainly attributed to the hydrophobic
interactions and the complementary character of both size and shape in the
molecular components.31,
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Therefore, host and guest combinations will form

inclusion complexes based on binding affinity with stronger affinity resulting in
more robust inclusion complexes and subsequent supramolecular architectures.
One of the principle advantages of supramolecular assemblies, and
particularly inclusion complexes, is that they are dynamic, easily reversible, and
can be customized to be responsive to various environmental and chemical stimuli
such as pH, light, temperature, voltage, etc.35, 44 Macrocyclic hosts are especially
attractive for this purpose because they offer a cavity with multiple recognition sites
for inclusion of a guest molecule, and can be tailored to promote self-assembly into
well-defined architectures by the addition of hydrophilic and/or hydrophobic chains
on either side of the macrocyclic framework.34
1.3.2.1 Cyclodextrin Hosts
There are several different classes of macrocyclic hosts such as calixarenes,
crown ethers, and cucurbiturils, but by far the most widely used hosts are
cyclodextrin (CD) derivatives.44 These macrocyclic oligosaccharides are composed
of several D-glucose rings with 𝛼-1,4 linkages, where 𝛼CD has six repeat units,
𝛽CD has seven, and 𝛾CD has eight.34, 44, 45 The truncated toroidal cone shape of
these molecules possess a hollow, tapered cavity of 0.79 nm in depth, where the top
and bottom diameters are influenced by the number of repeat units, as demonstrated
by Figure 13.45
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Figure 13: A closer look at the structure of cyclodextrin derivatives a) 𝛼CD, b)
𝛽CD, and c) 𝛾CD where the wider side of the cavity measures 0.57 nm, 0.78 nm,
and 0.96 nm, respectively, while the depth remains constant at 0.79 nm. Positions
2, 3, and 6 are indicated accordingly

This hollow interior cavity is hydrophobic, which is ideal for encapsulating guest
molecules of the appropriate size and shape for inclusion complexation, while the
exterior is hydrophilic, which is ideal for interacting with surrounding aqueous
media.44-46 Here, the CD itself may be amphiphilic based on synthetic
modifications, or the inclusion complex may create a supramolecular amphiphile
through non-covalent interactions. Inclusion complexation with a variety of guest
molecules and synthetic modifications of CDs have been extensively studied, and
perhaps the most powerful inclusion capacity is 𝛽CD with adamantane, with a
binding association constant of around 1x105 M-1 in water.34, 45, 46 It is important to
note that inclusion complexation innately alters the amphiphilicity of the CD, which
subsequently alters both the chemical and physical properties of self-assembled
bulk materials to make for advantageous easily customizable systems.
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Among the principle benefits of using CDs and their derivatives as hosts is
their excellent biocompatibility, unique inclusion complex formation capabilities,
powerful functionalization capacity with ease of synthetic modification, stability
across a wide range of pH (ie. 1-11), and negligible toxicity.34, 44-46 These properties
also make CDs ideal candidates for developing new drug delivery systems and
other materials used in biological systems. In fact, CDs have been utilized
extensively in this field with more than 30 CD based pharmaceuticals currently
marketed, and many others undergoing phase I/II trials.45 These supramolecular
assemblies have been shown to increase drug solubility and stability, enhance drug
absorption and permeability, control drug release profiles, decreasing toxicity,
etc.45 Because of the abundant hydroxyl groups on native CDs, chemical
modifications offer infinite opportunities to further improve upon the
aforementioned physiochemical properties and molecular recognition abilities for
specific applications. It is common to install charged groups, and either hydrophilic
or hydrophobic moieties at position(s) 2, 3, and/or 6 to achieve specific
functionality in bulk materials.44-46 Overall these synthetic modifications give rise
to three main classes of CDs- amphiphilic, hydrophobic, and polymer containing;
all of which have multiple recognition sites for binding molecules of varying
hydrophobicity/hydrophilicity. These hierarchical self-assemblies are especially
interesting when combined with polymers, since their unique characteristics depend
on individual molecules’ properties and polymers are known to possess extremely
useful properties on their own, which can be amplified using supramolecular
assemblies with CDs.45, 46
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1.3.3 Self-Assembly Features
Specifics of the numerous interactions that govern self-assembly of
amphiphiles is, in part, related to the amphiphilicity of individual molecules. The
degree of amphiphilicity is often termed the hydrophilic lipophilic balance, or
HLB.47 The HLB describes the size of the hydrophilic moiety relative to that of the
hydrophobic. This determines the mean radii of curvature of the hydrophobichydrophilic interface, which relates to the individual components’ radii of curvature
and the relevant Gaussian curvature to give the overall packing parameter that
determines what kind of nanostructures may form.47 For example, in order for an
amphiphile to form bilayers and/or bilayered vesicles in solution the product of the
hydrophobic-hydrophilic interfacial area and the alkyl chain length must approach
uniformity with the hydrophobic volume, which yields a packing parameter of 1.47
However, the HLB of amphiphiles not only determines what type of inclusion
complex and supramolecular architecture they may self-assemble into. Chemical
linkages may provide a triggered degradation mechanism for nanostructures which
is highly advantageous for developing stimuli responsive materials.44
Besides relevant size and shape of amphiphiles, thermodynamics also
govern the self-assembly of amphiphiles, as previously discussed in part in section
1.3.1, as these molecules aim to lower interfacial energy.40-43, 47, 48 Additionally,
concentration of amphiphile in solution also plays a part.49 Typically, the first
aggregates observed in solution are monolayers, and then some form of micelles.
Further increasing the concentration results in several more complex aggregates,
depending on the HLB and shape of the amphiphile, as demonstrated by Figure 14.
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Figure 14: The relationship between amphiphile concentration and temperature gives
rise to a variety of nanostructures of self-assembled supramolecular complexes

1.3.3.1 Vesicles
One particular aggregate omitted from Figure 13 is vesicles. Liposomes,
previously discussed in section 1.2.1, although sometimes termed interchangeably
with vesicles, are not the same on a molecular level. Liposomes refer to vesicles
formed from lipids, most commonly, phospholipids. Therefore, all liposomes are a
type of vesicle, specifically self-assembled from lipids, while vesicles may be selfassembled from all types of amphiphiles, including small molecules and polymers,
that exhibit the appropriate size, shape, HLB, etc. for bilayer, and subsequent
vesicle formation.47 Here, the lamellar bilayer observed in Figure 13 will begin to
fold upon itself to form a spherical vesicle in a two-step process.
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Although liposomes and vesicles possess the same overall macromolecular
shape that forms an aqueous interior separated from the bulk solution by one or
more bilayers of self-assembled amphiphiles, their physical and chemical
properties can vary quite dramatically.48 For example, their abilities to encapsulate
and release a payload in a sustained and controlled manner at a designated target
site varies based on the particular amphiphilic building blocks’ strength of noncovalent interactions and thickness of the bilayer membrane.47,
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Because the

membrane is a semi-permeable barrier, both nanostructures tend to suffer from
premature leakage of either hydrophobic or hydrophilic encapsulated payloads, and
yet vesicles tend to suffer less so than liposomes owing to their superior adaptability
to external environments.47-49 This is because phospholipids tend to hydrolyze
easily and so their liposomes have shorter shelf lives in aqueous solutions. In
general, compared to liposomes, vesicles tend to show superior dynamic stability
and mechanical strength/flexibility, and also offer much more numerous
opportunities for customizing physiochemical properties such as stimuli
responsiveness, and self-healing.47, 49 Particularly, polymeric vesicles demonstrate
excellent capability here, owing to the highly dynamic nature of polymers.
Characterization

of

vesicles

typically

includes

measurements

of

hydrodynamic radius, encapsulation ability, stability, stimuli responsivity,
controlled release kinetics, and overall shape and surface functionality.49
Hydrodynamic radius is most easily measured using dynamic light scattering,
wherein the size distribution of small aggregates suspended in solution are analyzed
as an intensity/photon autocorrelation function to account for fluctuations in
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aggregate distribution due to Brownian motion. Encapsulation ability can be probed
with a variety of methods which may include using a fluorescent small molecule as
a proof of concept, or a sample drug molecule for more specific measurements.
Herein, in order to determine whether vesicles have encapsulated a payload, they
must be destroyed, and the concentration of the encapsulated payload is then
measured. Stability measurements can be taken over time using dynamic light
scattering. The typical hydrodynamic radius of vesicles is on the order of 50-100
nm. When vesicles degrade, they may form micelles in solution which typically
have hydrodynamic radii of around 1-10 nm, or they may form even larger
aggregates with radii >>100 nm. Stimuli responsivity and controlled release
kinetics are often measured collectively, as it is of interest to see the controlled
release profile of vesicles in response to external stimuli. Herein, a particular
stimulus is applied and released concentration of encapsulated payload can be
measured using a variety of techniques including dialysis, UV spectroscopy, etc.
Finally, to get a morphological view of vesicles, scanning electron microscopy, xray photoelectron spectroscopy, transmission electron spectroscopy, etc. are used,
as previously discussed in section 1.1.1.3.
1.4 Dynamic Covalent Chemistry
While supramolecular chemistry has revolutionized the bottom-up
assembly of functional nanoscale materials with the dynamic reversibility of selfassembly that takes advantage of non-covalent interactions, dynamic covalent
chemistry exploits reversible covalent bonds to generate covalent systems that, like
supramolecular systems, can adapt, respond, and degrade in a controlled manner.50-
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Both allow the modification of molecular components; where supramolecular

chemistry provides molecular recognition and directed self-assembly in a
controlled manner beyond molecules, dynamic covalent chemistry imparts the
dynamic feature on the molecular level by breaking and forming covalent bonds
within molecules that may be used as building blocks in supramolecular selfassembly.52 Dynamic covalent chemistry has primarily been explored in the fields
of materials science, biotechnology, and medicine to create functional responsive
sensors, adaptive membranes, drug delivery systems, etc.50 By combining the
multivalent error correction and proofreading mechanisms of supramolecular
chemistry with the robustness and innate strength of covalent bond formation
dynamic covalent chemistry has evolved to offer potential improvement upon the
stimuli responsivity of supramolecular architectures.51 The key feature of these
reactions is the thermodynamically controlled product distribution at equilibrium.
Herein, the exchange of molecular components at equilibrium achieves a
thermodynamic minima of the system that is adaptable to the surrounding
environment, in which the most stable product will predominate.51, 52
Typically, reversible covalent reactions are undesirable and tedious
compared to supramolecular reactions because the breaking and forming of
covalent bonds has much slower kinetics, may require the use of a catalyst, and
result in low yields and low conversation rates.50, 51 Therefore, dynamic covalent
reactions with fast kinetics under mild conditions are preferable. In general, there
are a few requirements for dynamic covalent reactions to be useful for modifying
nanostructures on the molecular level.52,
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First, the lifetime of the reversible

covalent bond should be on the order of 1 ms < 𝜏 < 1 min, where 𝜏 is the bond
lifetime, to ensure that they are stable enough to bond molecular structures and yet
have dynamic behavior. The reaction must also be able to proceed under mild
reaction conditions, and the exchange mechanism should have a functional trigger
(ie. temperature, pH, light, removal of catalyst, redox), much like an on/off switch,
to isolate particular products.
Although dynamic covalent chemistry is a relatively new and insufficiently
explored field as of yet, there are numerous dynamic covalent reactions that have
been discovered and more or less optimized.50-52 Mostly, these reactions proceed as
exchange types, where one component is exchanged for another and the products
will have the same type of bonding as the reactants, or formation types, where new
types of bonds are formed.52 So far, dynamic covalent bonds that have been heavily
researched include C-C, C-O, C-N, C-S, B-O, and S-S (ie. carbon to carbon, carbon
to oxygen, carbon to nitrogen, carbon to sulfur, boron to oxygen, and sulfur to
sulfur, respectively). These dynamic covalent bonds and their subsequent reaction
possibilities are summarized in Table 1.50-52
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Table 1: Types of dynamic covalent chemistry reactions according to bond type

Type of Bond

C-C

C-N

C-O

C-S
B-O
S-S

Possible Dynamic Covalent Reactions
Aldol Reaction
Diels-Adler Reaction
Phenol/Aldehyde Condensation
Friedel-Crafts Reaction
Strecker Reaction
Olefin Metathesis
Alkyne Metathesis
Carbene Coupling
[2+1] Cycloaddition
C=N Formation/Exchanges
Aminal Formation
Amide Formation/Exchanges
Ester Formation/Exchanges
Acetal Formation/Exchange
Nicholas Ether-Exchange
Hemiaminal Ether Exchange
Alkyoxyamine Exchange
Thioacetal Exchange
Thiazolidine Exchange
Thia-Michael Reaction
Boronic Acid Condensation
Disulfide Exchange

1.4.1 Thiol-Disulfide Exchange
Of the types of dynamic covalent reactions listed in Table 1, the disulfide
exchange is of particular interest because of the biological significance it holds.
Disulfide bonds play an important role as part of the building blocks utilized in
protein folding (ie. the formation of secondary and tertiary structures) with both
intra and inter subunit crosslinking reactions.54, 55 Additionally, disulfides are the
major products of thiol oxidation, which is a biological process that’s primary role
is defense mechanisms against oxidative stress, as well as redox controlled cell-cell
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signaling.54 Disulfides are also key dynamic bonds responsible for many enzymes’
functionalities.54 This reaction is known to be highly robust, easily controllable,
and dynamic, and may proceed in the presence of any supramolecular structure to
create a reversible chemical system that is perhaps the most widely studied of any
dynamic covalent reaction.55
This disulfide exchange reaction proceeds as a three-step mechanism that
proceeds spontaneously, as demonstrated by Scheme 1.54, 55
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Scheme 1: Three step thiol-disulfide exchange reaction begins with a thiol
deprotonated to form the nucleophilic thiolate anion which attacks a sulfur atom to
form a new disulfide and thiolate anion. The former is then protonated to complete the
mechanism

This reaction proceeds by a simple SN2 type nucleophilic substitution with a single
transition state, and no intermediate formation. There have been some studies that
indicate this transition state is a linear trisulfide with the negative charge largely
delocalized, but most abundant on the attacking and leaving sulfurs.54 This
transition state can easily become too crowded and sterically hindered, so bulky
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functional groups will not work for this reaction. However, sterics may also
introduce strain on the disulfide bond which makes it more labile. Recent studies
suggest that the reaction is kinetically controlled, not thermodynamically, which
indicates that redox potentials and equilibrium constants will only indicate whether
the process is favorable, while the partitioning of particular pathways is rate
dependent.54 There are several factors that influence the rate of disulfide exchange
reactions, which are mainly focused on the pKa and nucleophilicity of the attacking
thiol group, but anything that may affect the stability of the leaving group or the
electrophilicity of the central disulfide sulfur are also important factors for
decreasing the activation energy barrier.54 Examining the rate law and kinetic
behavior of the reaction, it becomes clear that it cannot be fit to a simple first order
exponential equation that yields the apparent rate constant (kapp).54 This is because
disulfide exchanges will usually not reach completion, but rather a dynamic
equilibrium in which both products and reactants are present.
Instead, the reaction is easily controlled by adjusting the pH.54-56 Although
the reaction may proceed with an attacking thiol, the thiolate anion is a much
stronger nucleophile, and so deprotonating the thiol (ie. pH > pKa) is an easily
controllable molecular trigger to initiate the reaction which occurs quickly under
aqueous conditions.54-56 This molecular trigger is especially advantageous for
creating responsive functional materials for applications in biotechnology and
medicine because as previously mentioned in section 1.2.2, biological systems
naturally vary in pH. For example, the tripeptide glutathione (GSH), for which the
structure is shown in Figure 15, is a natural antioxidant found in both cytosolic fluid
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of cells and plasma. It has been demonstrated that the concentration range of
intracellular GSH is an order of magnitude higher than extracellular GSH
(ie.approximately 1-10 mM, and 1-10 𝜇M, respectively).57, 58 Additionally, in tumor
tissues, GSH concentration is even higher than that typically found in normal cell
tissues.

HS
O

O
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HO
NH2

H
N

O
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Figure 15: Chemical structure of glutathione (GSH) tripeptide structure in its reduced
form is composed of y-glutamate, cysteine, and glycine amino acid residues and may
serve as a nucleophile in disulfide exchange reactions

This appreciable difference in concentration makes GSH a suitable trigger to
stimulate release of an encapsulated payload in any nanocarrier, equip with a
disulfide bond, that is taken up into cells.56-58 Triggered release is predicted to be
more efficient in tumor cells than normal cells, as the higher GSH concentration in
tumor cells makes the disulfide exchange reaction more favorable. Although the
disulfide exchange reaction could theoretically occur at both intra- and extracellular
GSH concentrations, it has been proven that disulfide bonds are quite stable in
extracellular fluids, which is likely because the concentration of thiol is too low to
elicit a reaction.58
1.5 Nanomaterials
From antibacterial coatings for drug delivery to supramolecular and
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dynamic covalent chemistry, nanomaterials (ie. materials with dimensions of
approximately ≤100 nm) have been of heavily researched over the last century.59,
60

This is, in part, due to the broad availability of nanoscale materials and the

technological advances for characterizing them, but more so, controlling materials
properties on the nanoscale is highly advantageous.59 Atoms do not behave the
same way on the nanoscale as they do on the macroscopic scale. Hence, as the size
of materials decreases, the scalability of the principles that govern macromolecular
control over materials properties becomes quite challenging.60 However, the use of
nanomaterials has enhanced bulk material properties in ways that were never before
possible, which is why they are so exhaustively studied and applied in diverse
applications. The main challenges with developing new nano-based macromaterials
are specialized and financially draining characterization requirements, as well as
concerns over health and safety.59, 60 New technology is making the former issue
much more manageable, while the latter is still quite ambiguous. This is because
the physiochemical effects of nanomaterials on human physiological systems and
the environment is difficult to measure.59 It is presumed that since a very small
change in intricacies such as size, shape, surface functionality, charge, etc on the
nanoscale can elicit a large change in bulk material properties, that the same would
be true of living beings and their surrounding environment. Therefore, thorough
nanotoxicology studies are considered essential for the development of newly
developed nanomaterials to ensure their safety with widespread use, especially in
biotechnology and medicine.59

53

1.5.1 Vesicle Loaded Gel Networks
Previous sections (ie. 1.1-1.4) have addressed recent advances and issues in
some select topics of nanomaterials applications (ie. antibacterial coatings for drug
delivery, supramolecular chemistry, and dynamic covalent chemistry), and
although there have been remarkable developments in these fields individually, a
multidisciplinary approach may offer even more. Individually, perhaps the two
most promising candidates to create antibacterial coatings for drug delivery are
hydrogels and vesicles. Taking a look at their advantages, as previously mentioned
in sections 1.1.1 and 1.3.3.1, respectively, hydrogels demonstrate superior
biocompatibility, mechanical strength, and adaptability to the external
environment, largely owed to their porous crosslinking networks that allows them
to absorb water up to hundreds of times their own volume. Likewise, vesicles
demonstrate excellent encapsulation ability for both hydrophobic and hydrophilic
drugs, controlled release in response to certain stimuli, and overall biocompatibility
and stability. However, vesicles tend to suffer from rapid clearance in vivo while
hydrogels tend to suffer from limited encapsulation ability and rapid release of
encapsulated payloads.
Therefore, it is of interest to combine these two platforms to mitigate their
individual issues and combine their advantages. In fact, there has been a lot of upand-coming research done in this field that has demonstrated that the mechanical
strength and adaptability of hydrogels tends to stabilize the vesicles and prevent
rapid physiological clearance, while the vesicles tend to further stabilize the
hydrogel matrix and prevent rapid released of encapsulated payloads.61-74 This
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hybrid system also offers opportunities for implementing dual release mechanisms,
one for the hydrogel and one for the vesicles, as well as encapsulation of more than
one payload. The combination of supramolecular chemistry forming vesicles and
dynamic covalent bonds for triggered release mechanisms and/or crosslinking
network formation takes advantage of the programmed multivalent self-assembly
of supramolecular amphiphiles with the robustness of dynamic covalent bonds to
extend the applicability of both vesicles and hydrogels in drug delivery and
coatings.
1.6 Motivation and Research Plan
This study aims to create a novel antibacterial hydrogel coating by
embedding vesicles into a hydrogel coating, as visualized in Figure 16.

Figure 16: Schematic illustration of novel vesicle embedded hydrogel coating capable of
encapsulating two different payloads, with dual sustained release mechanisms
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This will mitigate burst release of encapsulated payload in the hydrogel, as well as
stabilize the vesicles for a longer shelf life. Vesicles will be prepared from a novel
supramolecular amphiphile composed of thio-alkyl modified 𝛽CD of varying chain
lengths (ie. 12 and 14 carbon) as the macrocyclic host (ie. 𝛽CD-C12, 𝛽CD-C14),
and an adamantyl-dicarboxylic acid-disulfide modified PEG (ie. AdSSPEG) with
an average degree of polymerization (DP) of 22 as the linear guest, as demonstrated
by Figure 17. This host-guest system will form inclusion complexes that selfassemble spontaneously to bilayered vesicles in aqueous solutions, which decreases
the number of synthetic steps to simplify preparation.

Figure 17: Schematic illustration of thioalkyl modified 𝛽CD-Cn host including the
adamantyl group of the AdSSPEG guest, which self assembles to form bilayers and then
bilayered vesicles in aqueous solutions

These vesicles will serve as three-dimensional multivalent junctions to form a
hydrogel through crosslinking of thiolated PEG through a dynamic disulfide
exchange reaction and will be capable of dual and selective release of two different
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encapsulated payloads. Herein, the vesicles are capable of encapsulating
hydrophobic or hydrophilic drugs in either its lipophilic bilayer membrane or
aqueous interior cavity, respectively, while the hydrogel may also encapsulate a
second drug during the crosslinking reaction. A pH sensitive acid labile bond
embedded in the thiolated PEG (PEGdiSH) crosslinker will cleave under acidic
conditions to release the payload enclosed in the hydrogel matrix, while a disulfide
bond embedded in the supramolecular amphiphile of the free vesicle can be cleaved
in the presence of GSH to release the second payload.

Figure 18: AdSSPEG and 𝛽CD-Cn inclusion complexes form a supramolecular
amphiphile that self-assembles to bilayered vesicles in aqueous solution. A) Vesicles are
crosslinked by PEGdiSH to form a hydrogel coating with two payloads encapsulated within
each of the vesicle and hydrogel during preparation B) Acidic environment will trigger the
cleavage of acid labile silyl-ether bond to release encapsulated payload from the hydrogel
medium C) Intracellular concentrations of glutathione will cleave the disulfide bond in the
AdSSPEG guest and remove the hydrophilic PEG to disrupt the ideal HLB and cause
release of encapsulated payload in the vesicle
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In this study, we will determine the ideal conditions for preparing the vesicle
loaded hydrogel coating and fully characterize the individual components as well
as the end product(s). The overall schematic is demonstrated by Figure 18.
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2. EXPERIMENTAL METHODS AND MATERIALS
2.1 Materials
All materials were used as received, unless otherwise stated. 𝛽Cyclodextrin

(𝛽CD),

triphenylphosphine

(PPh3),

1-tetradecanethiol,

1-

dodecanethiol, poly(ethylene glycol) (PEG; molecular weights 2000, 3400, 4000,
10000, and 20000 g/mol), anhydrous dichloromethane (DCM), anhydrous
tetrahydrofuran (THF), poly(ethylene glycol)-methyl ether (PEGOMe; molecular
weight 1000 g/mol), triethylamine (TEA), and nile red were purchased from TCI
Chemicals. Anhydrous dimethylformaldehyde (DMF), potassium-tert-butoxide (Kt-butoxide),

acetyl

chloride,

3,3-dithiopropionic

acid

(DTDP),

4-

dimethylaminopyridine (DMAP), 1-adamantol, and 5,6-carboxyfluorescin were
purchased from Acros Organics. Triton X-100, sephadex G-50, PEG (molecular
weights 200, and 1000 g/mol), and liquid bromine (Br2 (l)) were purchased from
Sigma Aldrich. L-glutathione (reduced), N,N’-dicyclocarbodiimide (DCC), and ptoluenesulfonyl chloride (TsCl) were purchased from Alfa Aesar. Anhydrous
pyridine was purchased from DriSolv. Thiourea was purchased from MCB.
Magnesium sulfate (MgSO4), and tris base were purchased from Fisher Chemical.
Polycarbonate 200 nm pore size membrane was purchased from Avanti Polar
Lipids, Inc. All other solvents and materials were received and/or prepared from
the Cal Poly Organic Chemistry Stockroom.
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2.2 Synthesis of Thioalkyl Modified 𝜷-Cyclodextrins (𝜷CD-C12, 𝜷CDC14)
2.2.1 Synthesis of Heptakis(6-bromo)- 𝜷CD
Br
O
HO
OH
O

7

[1]
Figure 19: Chemical structure of [1] Heptakis(6-bromo)- 𝛽CD

Native 𝛽-CD (4.0 g, 3.5 mmol) was dried over molecular sieves with
anhydrous DMF (≈20 mL) overnight (≈18 hours). The solution was transferred to
a round bottom flask, and solvent along with any residual water was removed under
reduced pressure. PPh3 (20 eq.) was added to a round bottom flask, dissolved in
anhydrous DMF (≈20 mL), and purged under nitrogen three times. Br2 (l) (20 eq.)
was then added dropwise to the PPh3 solution via nitrogen purged syringe and
stirred at 60 ℃ for 30 minutes. Dry 𝛽-CD was dissolved in anhydrous DMF (≈10
mL) and was then added to the reaction mixture dropwise and stirred overnight
(≈18 hours) at 80 ℃. Approximately half the solvent volume was then removed
under reduced pressure, and the resulting reaction mixture was added to methanol
(≈100 mL). The pH was adjusted to 10-12 with K-t-butoxide and the resulting
reaction mixture was stirred at room temperature for 30 minutes. This reaction
mixture was then precipitated in rapidly stirring ice-cold deionized water (DI
water). The precipitate was isolated via vacuum filtration, transferred to a falcon
tube, and then dissolved in methanol. The resulting solution was centrifuged
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(Eppendorf, Centrifuge 5810) three times in 5-minute intervals at 7500 RPM.
Methanol was decanted and the precipitate was transferred to a round bottom flask
and dissolved in a minimal amount of DMF. The solvent was then removed under
reduced pressure. Product was dried under high vacuum pump overnight (≈18
hours) to obtain a white powder [1].
2.2.2 Synthesis of Heptakis(6-dodecylthiol)- 𝜷CD (𝜷CD-C12),
Heptakis(6-tetradecylthiol)- 𝜷CD (𝜷CD-C14)
SC12H25

SC14H29

O

O

HO

HO
OH

OH
O

O

7

[2a]

7

[2b]

Figure 20: Chemical structure of [2a] Heptakis(6-dodecylthiol- 𝛽CD, and [2b]
Heptakis(6-tetradecylthiol)- 𝛽CD

Brominated 𝛽-CD [1] (350 mg, 0.22 mmol), either 1-dodecanethiol (for
[2a]) or 1-tetradecanethiol (for [2b]) (20 eq.), and K-t-butoxide (20 eq.) were
combined and purged under nitrogen three times. Anhydrous DMF (≈20 mL) was
added via nitrogen purged syringe to dissolve all reagents, and was allowed to stir
for 72 hours at 80 ℃. The reaction mixture was then precipitated in rapidly stirring
ice cold DI water. The precipitate was isolated via vacuum filtration, and
transferred to a round bottom flask. The precipitate was then refluxed (65 ℃) in
methanol (≈20 mL) for 1 hour. The resulting precipitate was isolated by vacuum
filtration and washed with hot methanol. The product was dried under high vacuum
pump overnight (≈18 hours) to obtain a white powder (n = 12) [2a] 1H NMR (400
61

MHz, Chloroform-d) δ 6.71 (s, 1H), 5.24 (s, 1H), 4.98 (s, 1H), 3.99 (t, 1H), 3.92 (t,
1H), 3.74 (t, 1H), 3.49 (t, 1H), 3.05 (d, 1H), 2.88 (m, 1H), 2.60 (t, 2H), 1.57 (m,
12H), 1.26 (m, 51H), 0.88 (t, 8H), or (n = 14) [2b] 1H NMR (400 MHz, Chloroformd) δ 6.71 (s, 1H), 5.24 (s, 1H), 4.97 (s, 1H), 3.99 (t, 1H), 3.91 (t, 1H), 3.74 (t, 1H),
3.49 (t, 1H), 3.04 (d, 1H), 2.88 (m, 1H), 2.60 (t, 2H), 1.55 (m, 15H), 1.25 (m, 29H),
0.88 (t, 4H).
2.3 Synthesis of Adamantyl-Dithiopropionic acid Modified
Poly(ethylene-glycol) / Poly(ethylene glycol)-methyl ether (AdSSPEG /
AdSSPEGOMe)
2.3.1 Synthesis of Dithiopropionic Anhydride
O

O
O
S
S

[3]
Figure 21: Chemical structure of [3] Dithiopropionic anhydride

DTDP (2.10 g, 10 mmol) was added to a round bottom flask and refluxed
(65 ℃) in acetyl chloride (10 eq.) for 2 hours. The reaction mixture was cooled to
room temperature, and acetyl chloride was removed under reduced pressure. The
resulting residue was precipitated in rapidly stirring ice-cold diethyl ether.
Precipitate was then isolated via vacuum filtration and washed with ice cold diethyl
ether. The product was dried under high vacuum pump overnight (≈18 hours) to
obtain an off-white powder [3].
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2.3.2 Synthesis of Dithiopropionic acid Modified Poly(ethylene glycol)
/ Poly(ethylene glycol)-methyl ether
O
HO

S

O

S

OH

O

22

O

[4a]

O
HO

S

O

S
O

O

O

22

[4b]
Figure 22: Chemical structure of [4a] Dithiopropionic acid-Poly(ethylene glycol), and
[4b] Dithiopropionic acid-Poly(ethylene glycol)-methyl ether

Either PEG (for [4a]) or PEGOMe (for [4b]) (6.5 g, 6.5 mmol) was dried
over molecular sieves with anhydrous DMF (≈20 mL) overnight (≈18 hours). The
solution was transferred to a round bottom flask, and solvent along with residual
water was removed under reduced pressure. Dithiopropionic anhydride [3] (2 eq.),
and DMAP (1 eq.) were added to the round bottom flask and all reagents were
dissolved in anhydrous DMF (≈20 mL). TEA (2 eq.) was added dropwise. The
resulting solution was purged under nitrogen three times and allowed to stir at 35
℃ for 36 hours. The reaction mixture was then precipitated in rapidly stirring icecold diethyl ether. The precipitate was isolated via vacuum filtration and washed
with ice cold diethyl ether. The product was then dried under high vacuum pump
overnight (≈18 hours) to obtain a brown powder [4a] or [4b].
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2.3.3 Synthesis of Adamantyl-Dithiopropionic acid Modified
Poly(ethylene-glycol) / Poly(ethylene glycol)-methyl ether (AdSSPEG /
AdSSPEGOMe)
O
S

O

O

S

[5a]

OH

O

22

O

O
S

O

O

S

O

O

O

22

[5b]
Figure

23:

Chemical

structure

of

[5a]

Adamantyl-Dithiopropionic

acid-

Poly(ethylene-glycol) (AdSSPEG), and [5b] Adamantyl-Dithiopropionic acidPoly(ethylene-glycol)-methyl ether (AdSSPEGOMe)

Dithiopropionic acid-PEG [4a] or dithiopropionic acid-PEGOMe [4b] (7 g,
5.87 mmol) was co-dissolved with 1-adamantol (2 eq.) in anhydrous DCM (≈20
mL) at 0 ℃. In a separate round bottom flask, DCC (2 eq) was also dissolved in
anhydrous DCM (≈ 5 mL) at 0 ℃. Both solutions were then purged under nitrogen
three times. DCC solution was added to the initial solution dropwise and stirred for
2 hours at 0 ℃. The reaction mixture was then allowed to stir for 22 hours at room
temperature. By product N,N’-dicyclourea (DCU) was removed by gravity
filtration. The filtrate was washed three times with 10% hydrochloric acid (HCl).
The aqueous layer was extracted with DCM until the organic layer appeared clear
(≈6 times). The organic layer was then washed three times with brine and dried
over MgSO4. The solvent was then removed under reduced pressure. The resulting
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residue was precipitated in rapidly stirring ice-cold heptane, isolated via vacuum
filtration, and washed with ice cold ether. The product was further purified in DI
water via dialysis (Float-A-Lyzer G2) with a 0.1-0.5 kDa pore membrane. The
resulting solution was flash-frozen with liquid nitrogen and left on the lyophilizer
(Labconco, FreeZone 4.5) overnight (≈18 hours) to remove water and obtain a
yellow-orange powder [5a] 1H NMR (400 MHz, DMSO-d6) δ 5.62 (s, 4H), 3.49 (s,
3H), 3.43 (s, 2H), 3.34 (s, 38H), 2.88 (s, 4H), 2.62 (s, 4H), 2.03 (s, 11H), 1.73 (s,
10H), 1.58 (s, 62H), or [5b] 1H NMR (400 MHz, Chloroform-d) δ 3.82 (s, 1H), 3.71
(s, 6H), 3.65 (s, 199H), 3.56 (s, 5H), 3.38 (s, 6H), 2.92 (s, 4H), 2.77 (s, 3H), 2.14
(s, 15H), 1.71 (s, 18H), 1.63 (s, 27H).
2.4 Synthesis of Thiol Modified Poly(ethylene-glycol) (PEG-diSH)
2.4.1 Synthesis of Poly(ethylene glycol)-di(p-toluenesulfonic acid)
(PEGdiOTs)

TsO

O

n

OTs

[6]
Figure 24: Chemical structure of [6] Poly(ethylene glycol)-di(p-toluenesulfonic acid)
(PEGdiOTs) (n = 22 [6a], 45 [6b], 77 [6c], 90 [6d], 227 [6e], 454 [6f])

PEG (n = 22 [6a], 45 [6b], 77 [6c], 90 [6d], 227 [6e], 454 [6f], 1.5 mmol)
was dried over molecular sieves with anhydrous DMF (≈20 mL) overnight (≈18
hours). The solution was transferred to a round bottom flask, and solvent along with
any residual water was removed under reduced pressure. TsCl (4 eq.) was added
and the resulting mixture was purged under nitrogen three times. Anhydrous
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pyridine (10 eq.) was then added at 0 ℃, and all reagents were dissolved in
anhydrous DCM (≈20 mL). The reaction mixture was stirred overnight (≈18 hours)
at 0 ℃. Three pieces of 7 cm diameter cellulose-based filter paper were cut up into
small pieces and added to the solution. The reaction mixture was then sonicated
(Ultrasonic Cleaner, GB-928) at 40 kHz for 1 hour to remove excess TsCl. The
filter paper was removed, and the reaction mixture was washed three times with
10% HCl. The aqueous layer was extracted with DCM until the organic layer
appeared clear (≈6 times). The organic layer was washed three times with brine
and dried over MgSO4. The solvent was removed under reduced pressure, and the
product was dried overnight (≈18 hours) under a high vacuum pump to obtain a
slightly yellow oil (n = 22 [6a]), or a slightly yellow powder (n = 45 [6b], 77 [6c],
90 [6d], 227 [6e], 454 [6f]).
2.4.2 Synthesis of Poly(ethylene glycol)-dithiol (PEGdiSH)
HS

O

n

SH

[7]
Figure 25: Chemical structure of [7] Poly(ethylene glycol)-dithiol (PEGdiSH) (n =
22 [7a], 45 [7b], 77 [7c], 90 [7d], 227 [7e], 454 [7f])

PEGdiOTs (n = 22 [6a], 45 [6b], 77 [6c], 90 [6d], 227 [6e], 454 [6f], 1 mmol)
was co-dissolved with thiourea (6 eq.) in anhydrous THF (≈ 15 mL) in a round
bottom flask. The resulting solution was purged under nitrogen three times and
allowed to reflux (66 ℃) overnight (≈18 hours). The reaction mixture is cooled to
room temperature and 10% NaOH (≈ 10 mL) was added through the top of the
condenser. The reaction mixture was again allowed to reflux (66 ℃) overnight (≈18
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hours). Once the layers separated, the organic layer solvent was removed under
reduced pressure and the aqueous layer was extracted three times with DCM. The
organic residue was dissolved in DI water, and the pH is adjusted to 7 with 10%
HCl. The organic layer was then extracted three times with DCM. All organic layers
were combined and washed three times with brine before drying over MgSO4.
Solvent was removed under reduced pressure and the product was dried under high
vacuum pump overnight (≈18 hours) to obtain a slightly yellow oil (n = 22) [7a]
1

H NMR (400 MHz, Chloroform-d) δ 3.81 (q, J = 4.6 Hz, 4H), 3.65 (s, 551H), 3.51

– 3.43 (m, 4H), 2.88 (s, 4H), 1.89 (s, 43H), or a slightly yellow powder (n = 45)
[7b] 1H NMR (400 MHz, Chloroform-d) δ 3.85 – 3.79 (m, 17H), 3.64 (s, 2567H),
3.51 – 3.43 (m, 18H), 2.88 (s, 4H), 1.80 (s, 451H), (n = 77) [7c] 1H NMR (400
MHz, Chloroform-d) δ 3.85 – 3.79 (m, 17H), 3.66 (s, 2483H), 3.49 – 3.44 (m, 18H),
2.88 (s, 4H), 1.43 (s, 4H), (n = 90) [7d] 1H NMR (400 MHz, Chloroform-d) δ 3.82
(dd, J = 5.8, 4.1 Hz, 4H), 3.64 (s, 995H), 3.47 (dd, J = 5.7, 4.1 Hz, 6H), 2.82 (s,
4H), 1.65 (s, 150H), (n = 227) [7e] 1H NMR (400 MHz, Chloroform-d) δ 3.85 –
3.78 (m, 15H), 3.65 (s, 2206H), 3.50 – 3.43 (m, 16H), 2.79 (s, 4H), 1.43 (s, 1H, (n
= 454) [7f]) 1H NMR (400 MHz, Chloroform-d) δ 3.85 – 3.79 (m, 16H), 3.65 (s,
6453H), 3.49 – 3.44 (m, 71H), 2.69 (s, 4H), 1.43 (s, 1H).
2.5 Nuclear Magnetic Resonance (NMR) Measurements
NMR (Bruker Ascend, 400 mHz) samples were prepared with
approximately 10 mg of compound dissolved in an appropriate solvent.
Compounds [2a, 2b, 5a, 5b, 7a-f] were analyzed via 1H NMR to confirm that final
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products were formed as expected. Novel compounds [5a, 5b] were also analyzed
via 13C NMR, and HSQC. MestreNova software was used to process all raw data.
2.6 Fourier-Transform Infrared (FTIR) Measurements
The FTIR (Perkin Elmer, Spectrum 100) crystal was cleaned with 2propanol and allowed to dry under ambient conditions. A background spectrum was
then recorded. Samples were deposited onto the crystal in order to cover it. Novel
compounds [5a, 5b] were analyzed for %Transmittance.
2.7 Inclusion Complex Formation
Host and guest (ie. thioalkyl modified βCD [2a, 2b] host, and adamantyldithiopropionic acid modified PEG / PEGOMe [5a, 5b] guest) were combined in
equimolar amounts (5 µmol) in a round bottom flask with DI water (≈ 2 mL) and
sonicated (Ultrasonic Cleaner, GB-928) at 40 kHz for 30 minutes. The solvent was
removed under reduced pressure to afford a thin film. The film was hydrated with
1:1 chloroform: DI water (≈ 2 mL total) and were again sonicated (Ultrasonic
Cleaner, GB-928) at 40 kHz for 30 minutes. The solvent was removed under
reduced pressure to afford the thin film inclusion complex. Inclusion complexes
were stable and stored in the fridge.
2.8 Vesicle Formation
Thin film inclusion complex was rehydrated with Tris buffer (10 mM Tris
base, 10 mM NaCl, pH 7.40, ≈ 1 mL) and allowed to sit for 30 minutes at room
temperature. This buffer solution was subjected to five freeze-thaw (liquid
nitrogen-55 ℃ water bath) cycles to form vesicles, and was then probe sonicated
(QSonica Sonicators, Ultrasonic Processor) at 20 kHz for 2 minutes to break up

68

larger aggregates. The solution was pushed through a 450 nm filter and then
extruded (Avanti Polar Lipids, Inc.) ten times with a 200 nm pore size
polycarbonate membrane (Avanti Polar Lipids, Inc.). Purified vesicles were stable
for several weeks to a month and stored in the fridge.
2.9 Fluorescent Vesicle Formation
Thin film hydration method from section 2.8 was used with 5,6carboxyfluorescin (CF) buffer (50 mM CF, 10 mM Tris base, 10 mM NaCl, pH
7.40, ≈ 1 mL) instead of Tris buffer. After extrusion, fluorescent vesicles were
further purified with size exclusion chromatography using a sephadex G-50
column. The column was prepared in a 5 mL syringe with 1:10 sephadex G-50: Tris
buffer. Sephadex G-50 was allowed to settle to the 3 mL mark before adding vesicle
containing CF buffer solution. The column was then eluted with Tris buffer, and a
fraction was collected for each colored band. Vesicles were in the orange band.
Vesicles with encapsulated CF were stored in the fridge. The column was reused
once all fluorescent dye had been eluted from the column.
2.10 Fluorimeter Measurements
Fluorimeter (Horiba Scientific, Fluorolog-QM) was set to the appropriate
experimental parameter and run at room temperature. Sample was loaded into a
quartz cuvette with a stir bar and stirred at speed 5 during all measurements.
FluorEssenceTM software was used for all data analysis.
2.10.1 Fluorescent Vesicle Encapsulation and Lysing via Fluorimetry
Fluorimeter (Horiba Scientific, Fluorolog-QM) was set to kinetics
acquisition with 𝜆=> = 517 nm with a slight width of 1 nm, and 𝜆=? = 492 nm with
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a slit width of 1 nm for fluorescent probe CF. Total run time was 90 seconds with
data collection every 0.1 seconds. Fluorescent vesicles prepared according to the
method in section 2.9 were diluted with Tris buffer (25 𝜇L vesicles, 2000 𝜇L Tris
buffer) and pipetted up and down to mix. Sample was then allowed to equilibrate
for 30 seconds before measurements were taken. The kinetics acquisition was
initiated, and a baseline was established for 30-40 seconds before adding 250 𝜇L
of 10% Triton X-100 detergent to lyse the vesicles. The percent change in
fluorescence intensity (%ΔFluorescence Intensity) was calculated using Equation
1, where 𝐼C = Fluorescence Intensity (CPS) at time t, and 𝐼D = Fluorescence Intensity
(CPS) at time 0.

% ∆𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 =

(ST U SV)
SV

∗ 100

EQ. 1

Results from this calculation determine whether vesicles were formed and
whether they encapsulated CF in their interior. A high %ΔFluorescence Intensity
comparing inclusion complexes, and host and guest molecules on their own (treated
with the same fluorescent vesicle formation method in section 2.9) was indicative
of successful vesicle formation and CF encapsulation.
2.10.2 Critical Aggregation Concentration (CMC) via Fluorimetry
Fluorimeter (Horiba Scientific, Fluorolog-QM) was set to spectra
acquisition with 𝜆=? = 515 nm with a slit width of 7 nm and 𝜆=> = 530 – 670 nm
with a slit width of 7 nm for fluorescent probe nile red. Samples were prepared at a
broad range of supramolecular amphiphile (ie. thioalkyl modified βCD [2a, 2b]
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host, and adamantyl-dithiopropionic acid modified PEG / PEGOMe [5a, 5b] guest
inclusion complexes) concentrations (0 – 500 𝜇M) with nile red concentration held
constant at 0.156 𝜇g/mL. Nile red stock solution (5 𝜇g/mL) was prepared in DCM
and was added to 5 mL volumetric flasks. Solvent was evaporated from the flasks
before amphiphile addition. Amphiphile was then added at the appropriate amount
and the sample was diluted to volume with nanopure water (Thermo Scientific,
Barnstead GenPure, 18.20 MΩ*cm). Each sample was sonicated (Ultrasonic
Cleaner, GB-928) at 40 kHz for 10 minutes and was then stored in vials for a few
hours before fluorimeter measurements were taken to allow for equilibration.
Fluorimeter measurements were taken in triplicate for each sample, and 𝜆>\? and
the Fluorescence Intensity (CPS) at 𝜆>\? were recorded.
Nile red behaves differently in aqueous environments versus lipophilic
environments, so when amphiphiles begin to form micelles the nile red will be
encapsulated in the hydrophobic interior and fluoresce at a higher wavelength and
intensity than in aqueous solutions.75 Therefore, by plotting fluorescence intensity
(CPS) at 𝜆>\? against amphiphile concentration (𝜇M), the slope approaches 0 at
the critical micelle concentration (CMC). Two linear fits can be made before (0)
and after (f) the CMC. Finding the intersection of these lines via Equation 2 will
give CMC (x).

(𝑚𝑥 + 𝑏)a = (𝑚𝑥 + 𝑏)D
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EQ. 2

2.11 Dynamic Light Scattering (DLS) Measurements
Dynamic light scattering (DLS) (Wyatt Tech, DynaPro NanoStar)
measurements were taken in disposable cuvettes in a dust free environment. The
cell temperature was set to 25 ℃ and the solvent was set to water for all samples.
If samples were clear, 100 𝜇L was loaded into the cuvette without scratching the
sides, the cap was placed, and measurements were taken after a 30 second
equilibration time. If samples were not clear, they were diluted with nanopure water
(Thermo Scientific, Barnstead GenPure, 18.20 MΩ*cm) until clear and loaded as
previously mentioned. For all samples, the average of 20 scans was used for data
collection and %Intensity, %PD (polydispersity), and hydrodynamic radius (nm)
were recorded. The sample was then aspirated out of the cuvette, and the cuvette
was rinsed several times with nanopure water (Thermo Scientific, Barnstead
GenPure, 18.20 MΩ*cm) before re-use.
2.11.1 Vesicle Particle Size via DLS
Vesicles prepared according to section 2.8 were measured on DLS (Wyatt
Tech, DynaPro NanoStar) according the method previously mentioned in section
2.11. To determine relative stability of vesicles, all vesicle samples were measured
repeatedly over the course of several weeks.
2.11.2 Vesicle Glutathione (GSH) Degradation via DLS
Vesicles prepared according to section 2.8 (with the modification of Tris
buffer pH = 8.5) were measured on DLS (Wyatt Tech, DynaPro NanoStar)
according the method previously mentioned in section 2.11. Initial measurements
were recorded, and then vesicle particle size stability was tested first with 10%
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Triton X-100, and then intracellular and extracellular concentrations of glutathione
(GSH). For 10% Triton X-100 degradation experiments, a 25 𝜇L aliquot of vesicles
was added to a vial with 2000 𝜇L of Tris buffer and 250 𝜇L 10% Triton X-100.
Sample was mixed by hand and measurements were taken immediately according
to the method previously mentioned in section 2.11. For intracellular [GSH]
degradation experiments, a GSH buffer (500 mM GSH, 10 mM Tris base, 10 mM
NaCl, pH 8.5) was prepared. A 25 𝜇L aliquot of vesicles was added to a vial with
2000 𝜇L of Tris buffer and 50 𝜇L of GSH buffer to give a final [GSH] = 12 mM,
which is just above the intracellular GSH range.57, 58 Samples were orbit mixed for
1 hour, and then overnight (≈18 hours), and measurements were taken at each time
increment according to the method previously mentioned in section 2.11. For
extracellular [GSH] degradation experiments, a GSH buffer (1 mM GSH, 10 mM
Tris base, 10 mM NaCl, pH 8.5) was prepared. A 25 𝜇L aliquot of vesicles was
added to a vial with 2000 𝜇L of Tris buffer and 40 𝜇L of GSH buffer to give a final
[GSH] = 20 𝜇M, which is just above the extracellular GSH range.57, 58 Samples were
orbit mixed for 1 hour, and then overnight (≈18 hours), and measurements were
taken at each time increment according to the method previously mentioned in
section 2.11. Initial measurements were compared to the measurements with 10%
Triton X-100, intracellular, and extracellular [GSH] to determine if any vesicle
degradation had occurred.
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2.12 Hydrogel Formation
Hydrogel formation was attempted with all vesicles prepared according to
section 2.8, and all PEGdiSH [7a-f] crosslinkers of varying molecular weight (ie.
1000, 2000, 3400, 4000, 10000, and 20000 g/mol).
Initial experiments were done at pH 7.4 at room temperature and PEGdiSH
wt/wt% 0.5, 1.0, 2.5, and 5.0 where PEGdiSH wt/wt% was calculated according to
Equation 3. Vesicle amount was held constant at 250 𝜇L.

𝑃𝐸𝐺𝑑𝑖𝑆𝐻 𝑤𝑡/𝑤𝑡% =

j=klmC na opqrkst uvaa=w
j=klmC na CnC\x uvaa=w

∗ 100

EQ. 3

Samples were prepared by combining vesicles in Tris buffer and PEGdiSH buffer
(1 mM PEGdiSH, 10 mM Tris base, 10 mM NaCl, pH 7.4) in the appropriate
amounts. Samples were vortex mixed for 30 seconds, and then orbit mixed
overnight (≈18 hours). Samples were checked every hour for 3 hours, and then
again after 24 hours, for hydrogel formation by inverting the vial to see if it can
hold its own weight.
Additional experiments were done at pH 8.5 at room temperature at
PEGdiSH wt/wt% 1.0, 2.5, 5.0, 10, and 20 where PEGdiSH wt/wt% was calculated
according to Equation 3. Vesicle amount was held constant at 250 𝜇L. Samples
were prepared by combining vesicles in pH modified Tris buffer (pH 8.5) and
PEGdiSH buffer (1 mM PEGdiSH, 10 mM Tris base, 10 mM NaCl, pH 8.5) in the
appropriate amounts. Samples were vortex mixed for 30 seconds, and then orbit
mixed overnight (≈18 hours). Samples were checked every hour for 3 hours, and
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then again after 24 hours, for hydrogel formation by inverting the vial to see if it
can hold its own weight.
Further experiments were done with the aforementioned 20 wt/wt%
PEGdiSH containing samples. These samples were incubated at temperatures 30,
35, 40, 45, and 50 ℃ for 2 hours each, and checked for hydrogel formation every
30 minutes by inverting the vial to see if it can hold its own weight.
Final experiments were done at pH 8.5, temperatures 25, 35, 45 and 55 ℃,
and PEGdiSH wt/wt% 10 and 20, where PEGdiSH wt/wt% was calculated
according to Equation 4. Vesicle amount was gradually increased after each
temperature incubation from 10, 20, 40, 60, 80, 100, to 250 𝜇L. PEGdiSH amount
was held constant at 250 𝜇L.

𝑃𝐸𝐺𝑑𝑖𝑆𝐻 𝑤𝑡/𝑤𝑡% =

j=klmC opqrkst
j=klmC na ywkz uvaa=w

∗ 100

EQ. 4

Samples were prepared by combining vesicles in pH modified Tris buffer (pH 8.5)
and PEGdiSH in pH modified Tris buffer (pH 8.5) in the appropriate amounts.
Samples were vortex mixed before being allowed to incubate at each of the
previously mentioned temperatures for 1 hour each and are checked for hydrogel
formation every 30 minutes by inverting the vial to see if it can hold its own weight.
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3. RESULTS AND DISCUSSION
3.1 Synthesis of Thioalkyl Modified 𝜷-Cyclodextrins (𝜷CD-C12, 𝜷CDC14)
Thioalkyl modified 𝛽CDs [2a, 2b] were synthesized according to Scheme 2
and were characterized via 1H NMR to confirm that the macrocyclic host molecules
were formed as expected.
Br

OH
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O

Br2, PPH3, DMF

HO

HO
OH
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O

7

7

[1]
SCnH2n+1
O
K + -O

t-butyl, HSCnH2n+1

HO
OH
O

7

[2]
Scheme 1: Synthesis of [1] Heptakis(6-bromo)- 𝛽CD, and [2] Heptakis(6-thioalkyl)- 𝛽CD
(n= 12 [2a], 14 [2b])

After the initial bromination at position 6 of the native 𝛽CD, the thioalkyl chain
was covalently attached via an SN2 substitution reaction. Products [2a, 2b] were
then isolated via a hot methanol reflux, filtration, and centrifugation to remove
excess unreacted free thiol from the precipitate. It was found that increasing
reaction times

increased the overall yield from this synthetic pathway, and

persistent centrifugations in addition to vacuum filtrations were effective methods
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to purify the final products [2a, 2b]. Hot methanol filtration and washing in the final
step was essential in removing free unreacted alkyl thiol.

Figure 26: 1H NMR of βCD-C12 [2a] in deuterated chloroform (CDCl3)
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Figure 27: 1H NMR of βCD-C14 [2b] in deuterated chloroform (CDCl3)

Proton NMRs in Figures 26 and 27 correspond to 𝛽CD-C12 [2a] and 𝛽CDC14 [2b], respectively. Here, peaks labeled a, b, c, d, and e correspond to protons
within the core glucose structure. Peak f corresponds to protons at position 6 where
the thioalkyl chain has been covalently bound. The triplet peak g corresponds to the
protons directly besides the sulfur atom, as they are downfield due to deshielding
effect from the sulfur. The appearance of this peak at 2.60 ppm was used to confirm
final product formation. Peak h corresponds to the rest of the protons on the
thioalkyl chain, while peak i corresponds to the terminal methyl protons. Overall,
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both 𝛽CD-C12, 𝛽CD-C14 [2a, 2b] were synthesized successfully and in good yield
(78-86%).
In Figure 26, excess free unreacted alkyl thiol was still present in the final
product, but it is in such a small amount compared to the 𝛽CD-C12 [2a] product
that the material was deemed pure enough for use in subsequent experiments.
Additionally, the excess alkyl thiol does not have the necessary amphiphilicity and
geometry needed to form inclusion complexes or self-assemble on its own, so it is
not a concern for interfering with subsequent experiments. The 𝛽CD-C12, and
𝛽CD-C14 [2a, 2b] products on their own have very poor water solubility which can
be attributed to the hydrophobic thioalkyl modification along with the hydrophobic
core of the truncated cone structure. However, the exterior of the truncated cone
structure is hydrophilic due to the stereochemistry of the abundant hydroxyl groups
on the core glucose structure facing outwards, which overall makes these
macrocyclic host molecules amphiphilic on their own.
3.2 Synthesis of Adamantyl-Dithiopropionic acid Modified Poly(ethyleneglycol) (AdSSPEG, AdSSPEGOMe)
Novel adamantyl-dithiopropionic acid modified poly(ethylene glycol)s
(AdSSPEG, AdSSPEGOMe) [5a, 5b] were synthesized according to Scheme 3 and
4 and characterized via 1H NMR, 13C NMR, HSQC, and FTIR to confirm that linear
guest molecules were synthesized as expected.
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Scheme 2: Synthesis of [3] Dithiopropionic anhydride, [4a] Dithiopropionic acidpoly(ethylene glycol), and [5a] Adamantyl-dithiopropionic acid-poly(ethylene glycol)
(AdSSPEG)
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Adamantyl-dithiopropionic

acid-

Initially, DTDP was cyclized to form an anhydride. The anhydride ring was then
opened via alcohol addition to covalently attach PEG (for [5a]) or PEGOMe (for
[5b]). DCC was used as a coupling agent to attach an adamantane group to the
terminal carboxylic acid of [4a] or [4b] to form the final product [5a] or [5b]. The
first two steps of this synthetic pathway were simple and straightforward to execute
in practice, while the final step required much more effort to isolate a pure final
product due to the strong amphiphilicity of the linear guest molecules creating
solubility challenges. PEG / PEGOMe molecules of 1000 g/mol were used because
PEG with lower molecular weights are much more soluble in diethyl ether, and
hence much more difficult to isolate via precipitation as a purification method.
Additionally, lyophilizing the final product after dialysis was instrumental in
removing all excess water and obtaining a pure product. Due to the amphiphilicity
of the products, water was unable to be completely removed via rotary evaporation.
Lyophilization was preferable because it converts water straight from the solid
phase to the gas phase, while rotary evaporation converts water from the liquid
phase to the gas phase. This is because the solid to gas transition occurs at a much
lower temperature than the liquid to gas transition which decreases the amphiphilic
molecules’ ability to hold onto water molecules.
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Figure 28: 1H NMR of AdSSPEGOMe [5b] in deuterated chloroform (CDCl3)
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Figure 29: 1H NMR of AdSSPEG [5a] in deuterated dimethylsulfoxide (DMSO)

Proton NMRs in Figures 28 and 29 correspond to AdSSPEGOMe and
AdSSPEG [5b, 5a], respectively. Here, peaks labeled g and h correspond to protons
within the adamantane group structure. Peak a corresponds to protons within the
ethylene glycol repeat group, while peak b corresponds to the end group. For
AdSSPEGOMe, this is three methyl protons, while for AdSSPEG this is one
hydroxyl proton. Hydroxyl protons are known to have unreliable and broad
chemical shifts (if they show up at all), so although the integration for the hydroxyl
proton indicates four protons, it is actually just one. Peaks c and d correspond to
the protons between the repeat group and the ester linkage, which were used to
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confirm that the final product formed. The nearby oxygens on the ester group
deshield these protons which pushes them slightly downfield of the rest of the PEG
protons. Similarly, peaks f and e correspond to protons between the ester and
disulfide linkages, where the disulfide group is less deshielding than the
surrounding oxygens which results in these triplet peaks being upfield the PEG
protons.

Figure 30: 13C NMR of AdSSPEGOMe [5b] in deuterated chloroform (CDCl3)

84

Figure 31: 13C NMR of AdSSPEG [5a] in deuterated dimethylsulfoxide (DMSO)

Carbon NMRs in Figures 30 and 31 correspond to AdSSPEGOMe and
AdSSPEG [5b, 5a], respectively. Here, carbonyl peaks labeled C=O correspond to
the two ester peaks in the core of the guest molecule structure. They exhibit
different chemical shifts as they are not equivalent due to the adamantyl linkage on
one and PEG linkage on the other having different electron densities. The PEG
group electron density is much lower than that of the adamantane group, which

85

causes the ester carbon attached to the PEG group to be more deshielded and appear
slightly downfield from the ester carbon attached to the adamantane group.

Figure 32: HQSC two-dimensional NMR of AdSSPEGOMe [5b] in deuterated chloroform
(CDCl3) shows correlations between 13C NMR and 1H NMR peaks
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Figure 33: HQSC two-dimensional NMR of AdSSPEG [5a] deuterated dimethylsulfoxide
(DMSO) shows correlations between 13C NMR and 1H NMR peaks

HSQC two-dimensional NMRs in Figures 32 and 33 correspond to
AdSSPEGOMe and AdSSPEG [5b, 5a], respectively. They both show strong
correlations between the proton and carbon NMR peaks.
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Figure 34: FTIR of AdSSPEGOMe [5b]

Figure 35: FTIR of AdSSPEG [5a]

FTIR spectra in Figures 34 and 35 correspond to AdSSPEGOMe and
AdSSPEG [5b, 5a], respectively. Here, we can see a clear difference between the
two structures which confirms singular substitution was achieved on the hydroxyl
terminated AdSSPEG [5a], as we can see a clear hydroxyl peak around 3300 cm-1
in Figure 35, which is absent in Figure 34 with the methyl terminated
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AdSSPEGOMe [5b], as expected. Typically, hydroxyl peaks on an FTIR spectra
are broad but with AdSSPEG [5a] the peak is sharp. This is likely due to the other
functional groups present in the polymer providing a shielding effect and
decreasing the hydroxyl signal. Overall, both AdSSPEG and AdSSPEGOMe [5a,
5b] were synthesized successfully and in good yield (69-74%).
Synthetically, the AdSSPEGOMe [5b] derivative is much easier to
synthesize as di-substitution of the PEG molecule does not have to be considered.
Final products AdSSPEG and AdSSPEGOMe [5a, 5b], although structurally very
similar, exhibit much different behavior in aqueous solutions. Dialysis with the
AdSSPEG [5a] derivative required ethanol addition as a co-solvent to get the guest
molecule to go into solution, which was not necessary with the AdSSPEGOMe [5b]
derivative as it was water soluble on its own. This is due to the hydroxyl versus
methyl groups terminating the PEG chain. Here, the hydroxyl group pulls electron
density away from the PEG chain, while the methyl group does not. This creates an
overall stronger dipole moment for the methyl terminated guest than the hydroxyl
terminated guest which explains the difference in water solubility.
3.3 Synthesis of Thiol Modified Poly(ethylene-glycol) (PEG-diSH)
Thiol terminated linear PEG molecules (PEGdiSH) [7a-f] were synthesized
according to Scheme 5 at various molecular weights (ie. 1000, 2000, 3400, 4000,
10000, and 20000 g/mol), and characterized via 1H NMR to confirm that linear
crosslinking molecules were synthesized as expected.
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Scheme 4: Synthesis of [6] Poly(ethylene glycol)-di(p-toluenesulfonic acid) (PEGdiOTs),
and [7] Poly(ethylene glycol)-dithiol (PEGdiSH) (n = 22 [7a], 45 [7b], 77 [7c], 227 [7e], 454
[7f])

The ditosylation of PEG yielded excess unreacted TsCl that was very difficult to
remove via aqueous workup. Instead, cellulose based filter paper was used to
remove the excess TsCl. Here, the free hydroxyl groups in the cellulose structure
are able to react with the excess TsCl when base is present to facilitate the
substitution reaction in order to covalently bind the TsCl to the filter paper.76
Therefore, the excess TsCl is able to be removed manually along with the filter
paper. This method has proven to be extremely reliable and useful in obtaining a
pure final product for use in the next synthetic step. The tosyl group provides a
good leaving group for the nucleophilic SN2 double substitution reaction in the next
step, where both sides of the PEG chain covalently bind to the thiol. Addition of
base then creates urea as a side product as the final product of dithiolated PEG
(PEGdiSH [7]) is formed.
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Figure 36: 1H NMR of PEGdiSH (n = 90 [7d], 4000 g/mol) in deuterated chloroform
(CDCl3)

The proton NMR in Figure 36 corresponds to PEGdiSH (n = 90 [7d]). Proton NMRs
for PEGdiSH (n = 22 [7a], 45 [7b], 77 [7c], 227 [7e], 454 [7f]) can be found in the
appendix. Here, peaks labeled a correspond to the ethylene glycol protons in the
repeat unit. It is likely that there are varying amounts of free unreacted PEG from
the first step of this two-step synthesis, as the integrations are much more than
would be expected for each of these polymers. However, NMR is not the most
optimal way to characterize polymers, so it is also possible that electrostatic effects
from the polymer chains are overlapping and hence interfering with the peak
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intensities to cause the discrepancy in integration values. Peaks labeled b and c
correspond to the protons bonded to the two carbons closest to the terminal thiol
group on each side of the polymer. Peak c is slightly more upfield than peak b
because the thiol group is more shielding than the oxygen group nearby. Peaks
labeled d may correspond to the terminal thiol protons. These integrations are also
not what we would expect because thiol protons, like hydroxyl protons, are known
to have broad and unreliable peaks in 1H NMRs, if they show up at all. Additionally,
peak d may also correspond to some type of grease, as this is also known to show
up in the range of 1 ppm. Hence, the disappearance of tosyl proton peaks around 78 ppm and the appearance of peak c at 2.8 ppm were used to confirm the formation
of the final PEGdiSH [7] products.
PEGdiSH (n = 90 [7d], 227 [7e], and 454 [7f]) molecules are the purest
comparatively, with only trace solvent peaks remaining from DMF and acetone.
PEGdiSH (n = 22 [7a], 45 [7b], and 77 [7c]) had some other trace impurities
present, but the molecules were deemed pure enough to use in subsequent reactions
since these impurities had relatively small signals compared to the signals from the
final product. Overall, PEGdiSH [7a-f] molecules were synthesized successfully.
Yields from this synthetic pathway (27-48%) were not as high as we would
typically like them to be for organic substitution reactions, but since all the starting
materials are so inexpensive and widely available, the reactions did not need to be
further optimized for our purposes.
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3.4 Inclusion Complex Formation
Inclusion complexes were formed according to the method described in
section 2.7, which is also demonstrated in Figure 37, by taking advantage of the
hydrophobic effect through combining host and guest molecules in an aqueous
environment. Here, the thioalkyl modified 𝛽CDs [2a, 2b] have very poor water
solubility, so it is necessary to sonicate to help them go into solution so that host:
guest inclusion complexes could be formed.

Figure 37: Supramolecular amphiphile inclusion complex formation method with thioalkyl
modified 𝛽CD [2a, 2b] host, and adamantyl-dithiopropionic acid modified PEG /
PEGOMe [5a, 5b] guest. The hydrophobic effects drives inclusion when combining host
and guest molecules in aqueous media, which affords a thin film inclusion complex to be
used in future vesicle formation methods

Four different host: guest combinations were made and tested- 𝛽CDC12:AdSSPEGOMe, 𝛽CD-C12:AdSSPEG, 𝛽CD-C14:AdSSPEGOMe, and 𝛽CD93

C14:AdSSPEG. Here, C12 and C14 indicate the thioalkyl chain length attached to
position 6 of the 𝛽CD. In this preparation method, sonication is an important step
which helps bring the host and guest molecules into solution in order to drive
inclusion complex formation. The process is repeated twice to give a higher
probability that the inclusion complex will have formed. There are several methods
commonly used to test for inclusion complex formation which often include
examining the host and guest molecules on their own, a physical mixture of the host
and guest molecules, and the inclusion complex. Among these are NMR,
differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA).
NMR is not a particularly reliable method especially with non-ionic inclusion
complexes, because it is likely that the chemical shifts will not show a distinct
change with inclusion complexation. Here, the 𝛽CD inclusion complexes are not
very water soluble, so obtaining comparable NMR data from hosts and guests on
their own is also very difficult because the spectra appear broad and it is difficult
to discern chemical shifts in peaks of interest. DSC and TGA measurements
measure differences in phase transition and degradation temperatures, respectively.
These methods are not useful in this case because we are not interested in these
properties of our inclusion complexes, as they are designed to be used under
physiological conditions, there is simply no need to test them at extreme conditions.
Here, inclusion complex formation was confirmed through CMC testing with host
and guest on their own compared to inclusion complexes, as described in sections
2.10.2 and 3.5. This is because the CMC is an important parameter for amphiphilic
self-assembly as it gives the minimum concentration required to form aggregates
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with a particular supramolecular amphiphile in aqueous solutions. All four
supramolecular amphiphile inclusion complexes efficaciously and consistently
form, as further discussed in section 3.5.
3.5 Critical Aggregation Concentration (CMC) via Fluorimetry
Nile red was chosen as a fluorescent probe for determining CMC because
of its unique behavior in aqueous versus organic solutions. As demonstrated by
Figure 38, nile red exhibits different emission wavelengths depending on whether
it exists in a hydrophilic or a lipophilic environment.75

Figure 38: Nile red emission spectra in aqueous environments (𝜆=?{kC\Ckn| = 515 nm,
𝜆=>kzzkn| = 585 nm) compared to lipid environments (𝜆=?{kC\Ckn| = 554 nm, 𝜆=>kzzkn| =
638 nm) shows a notable shift in wavelength
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The stokes shift, or the difference in energy between excitation and emission bands,
is slightly larger for the lipophilic environment which makes it easier to detect with
emission spectroscopy. Experimentally, a broad emission from approximately 530640 nm was observed for amphiphile concentrations below the CMC, while a sharp
emission at 638 nm was observed at amphiphile concentrations above the CMC.
Nile red on its own is practically insoluble in water, so it tends to migrate
to the air-water interface of aqueous solutions. When amphiphile is added to this
solution, the nile red will be attracted to the hydrophobic moieties. As concentration
of amphiphile is increased amphiphile will begin to self-assemble into a monolayer,
and eventually a micelle due to the hydrophobic effect, as previously mentioned in
section 1.3.2. Since the nile red is attracted to the hydrophobic moieties, it becomes
encapsulated in the lipophilic interior of the micelle once formed, which then alters
its fluorescence behavior. This process is summarized in Figure 39.
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Figure 39: As amphiphile concentration is increased in aqueous solutions, amphiphilic
molecules are driven to self-assemble into monolayers and eventually micelles due to the
hydrophobic effect. Nile red becomes encapsulated in the lipophilic interior of the micelle
as it is attracted to its hydrophobicity

Fluorescence spectroscopy was ran according to the method described in
section 2.10.2 with each inclusion complex (ie. 𝛽CD-C12:AdSSPEGOMe, 𝛽CDC12:AdSSPEG, 𝛽CD-C14:AdSSPEGOMe, and 𝛽CD-C14:AdSSPEG), as well as
the linear AdSSPEGOMe [5b] guest molecule on its own. The guest molecule was
tested on its own to confirm that the inclusion complexes are forming unique
supramolecular amphiphiles, and that we were not just observing the self-assembly
of the guest molecule. Macrocyclic 𝛽CD-C12 [2a] and 𝛽CD-C14 [2b] hosts were
not tested on their own due to their poor water solubility. Because of this, it is highly
impractical that they would self-assemble on their own. Overall, this method
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yielded consistent results, and for each sample there was a note-able difference in
𝜆=> maximum before and after the CMC, which was as expected since nile red
emits at higher wavelengths in lipophilic environments, such as the interior of a
micelle. Raw data in Figure 40 demonstrates this difference for one sample before
and after the CMC.

40 μM AdSSPEGOMe1000:𝛽CDC12 in Nile Red
Fluoresceunce Intensity (CPS)

Fluorescence Intensity (CPS)

20 μM AdSSPEGOMe1000:𝛽CDC12 in Nile Red
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AdSSPEGOMe:𝛽CD-C12 before the CMC at 585 nm (left) and after the CMC at 638 nm
(right). Initial excitation at 515 nm before the CMC (left) is not shown because wavelengths
were only monitored in the range of 530 – 670 nm. Excitation was at 554 nm after the CMC
(right)
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Figure 41: AdSSPEGOMe [5b] linear guest molecule CMC measured via fluorescence
emission spectroscopy at approximately 638 nm and various concentrations of amphiphile
and nile red held constant at 0.156 𝜇g/mL. CMC was found to be 200.54 𝜇M
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Figure 42: AdSSPEGOMe:𝛽CD-C12 inclusion complex CMC measured via fluorescence
emission spectroscopy at approximately 638 nm and various concentrations of amphiphile
and nile red held constant at 0.156 𝜇g/mL. CMC was found to be 30.50 𝜇M
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Figure 43: AdSSPEGOMe:𝛽CD-C14 inclusion complex CMC measured via fluorescence
emission spectroscopy at approximately 638 nm and various concentrations of amphiphile
and nile red held constant at 0.156 𝜇g/mL. CMC was found to be 27.16 𝜇M
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Figure 44: AdSSPEG:𝛽CD-C12 inclusion complex CMC measured via fluorescence
emission spectroscopy at approximately 638 nm and various concentrations of amphiphile
and nile red held constant at 0.156 𝜇g/mL. CMC was found to be 37.85 𝜇M
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Figure 45: AdSSPEG:𝛽CD-C14 inclusion complex CMC measured via fluorescence
emission spectroscopy at approximately 638 nm and various concentrations of amphiphile
and nile red held constant at 0.156 𝜇g/mL. CMC was found to be 35.97 𝜇M

Table 2: CMC results for all inclusion complexes and AdSSPEGOMe guest molecule on
its own confirm inclusion complex formation, and give the minimum aggregation
concentrations required for self-assembly

Sample

CMC (𝝁M)

AdSSPEGOMe1000:𝜷CD-C12

30.50

AdSSPEGOMe1000: 𝜷CD-C14

27.16

AdSSPEG1000: 𝜷CD-C12

37.85

AdSSPEG1000: 𝜷CD-C14

35.97

AdSSPEGOMe1000

200.54

Figures 41-45 and Table 2 summarize these results. For each sample, we
see a stark difference in slope before and after the CMC, which was as expected.
Here, the AdSSPEGOMe [5b] guest molecule (Figure 41) was shown to exhibit a
CMC at more than five times that of all the inclusion complexes (Figures 42-45),
101

as it is more soluble in water on its own than it is when it is included in the thioalkyl
modified 𝛽CD host. Additionally, thioalkyl 𝛽CD inclusion complexes with longer
alkyl chains (ie. C14) have lower CMCs, which is also consistent with the principles
of the hydrophobic effect and micellization; longer alkyl chains are less soluble in
aqueous solutions and therefore tend to aggregate at lower concentrations than
molecules with shorter alkyl chains. Similarly, AdSSPEG [5a] inclusion complexes
have slightly higher CMCs than AdSSPEGOMe [5b] inclusion complexes, which
could be due to the terminal hydroxyl group of AdSSPEG [5a] having more
hydrogen bonding ability than the methyl ether group and hence increasing water
solubility. These results were useful for subsequent vesicle formation reactions as
the minimum aggregation concentration was increased to form vesicles, and the
minimum amount of materials was used.
3.6 Vesicle Formation
Vesicles were formed according to the method described in section 2.8,
which is also demonstrated in Figure 46. Here, thin film inclusion complexes, as
demonstrated by Figure 47, are suitable for rehydration to form vesicles via this
method.
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Figure 46: Thin film inclusion complex with thioalkyl modified 𝛽CD [2a, 2b] host, and
adamantyl-dithiopropionic acid modified PEG / PEGOMe [5a, 5b] guest is rehydrated with
Tris buffer and subjected to five freeze-thaw cycles to afford vesicles. The solution is probe
sonicated to break up any larger aggregates, filtered, and extruded to obtain pure
monodisperse vesicles

Figure

47:

Inclusion

complexes

βCD-C12:AdSSPEG

(left),

and

βCD-

C14:AdSSPEGOMe (right) form thin films in round bottom flasks that are suitable for
rehydration to form vesicles
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Four different inclusion complexes were used to make vesicles- 𝛽CDC12:AdSSPEGOMe, 𝛽CD-C12:AdSSPEG, 𝛽CD-C14:AdSSPEGOMe, and 𝛽CDC14:AdSSPEG. Controls with AdSSPEGOMe [5b], AdSSPEG [5a], 𝛽CD-C12
[2a], and 𝛽CD-C14 [2b] on their own were also tested to further confirm that only
the inclusion complexes self-assemble to bilayered vesicles. Freeze-thaw cycles
“shock” the supramolecular amphiphiles and helps drive their self-assembly, while
probe sonication breaks up larger aggregates that may have formed during this
process. Filtering removes these larger particles, and extrusion further purifies the
vesicle solution to obtain a more monodisperse sample. Probe sonication and
extrusion methods were used to together as this method yielded the most consistent
and stable vesicles as compared to just extrusion or just probe sonication as an
isolation method, which will be further discussed in section 3.9. Vesicle solutions
in Tris buffer were made at pH 7.4 and 8.5.
For this project we did not have access to high resolution microscopy such
as SEM to confirm vesicle formation, so in order to confirm that vesicles were
forming as expected, we encapsulated a fluorescent dye in the vesicle interior and
destroyed them, as described in section 2.10.1 and discussed in section 3.8, and
measured their particle size using dynamic light scattering to see if they were
consistent with literature references, as described in section 2.11.1 and discussed in
section 3.9. Overall, none of the control samples formed vesicles. All inclusion
complexes formed vesicles consistently, and their particle sizes were consistent
with literature values (100-250 nm diameter),61-74 and were stable for several weeks
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up to approximately one month before degradation and/or aggregating into larger
particles.
3.7 Fluorescent Vesicle Formation
Fluorescent vesicles were formed according to the method described in
section 2.9, which is also demonstrated in Figure 48.

Figure 48: Thin film inclusion complex with thioalkyl modified βCD [2a, 2b] host, and
adamantyl-dithiopropionic acid modified PEG / PEGOMe [5a, 5b] guest is rehydrated with
CF buffer and subjected to five freeze thaw cycles to afford vesicles. The solution is probe
sonicated to break up any larger aggregates, filtered, and extruded. The resulting vesicle
containing solution is further purified with a sephadex G-50 column to obtain pure
monodisperse vesicles with encapsulated CF

Four different inclusion complexes were used to make fluorescent vesicles- 𝛽CDC12:AdSSPEGOMe, 𝛽CD-C12:AdSSPEG, 𝛽CD-C14:AdSSPEGOMe, and 𝛽CD105

C14:AdSSPEG. Controls with AdSSPEGOMe, AdSSPEG, 𝛽CD-C12, and 𝛽CDC14 on their own were also tested to further confirm that only the inclusion
complexes self-assemble to bilayered vesicles. This method is similar to the
previously discussed vesicle formation method in section 3.6, with the modification
of a fluorescently labeled CF buffer, and a sephadex G-50 column to remove free
CF that was not encapsulated in the vesicle interior and any smaller aggregates that
may have survived extrusion.
This sephadex G-50 column is a size exclusion chromatography method
which elutes larger particles first as they are not absorbed into the porous medium
like smaller particles are. This method allows for the isolation of pure monodisperse
vesicles with encapsulated fluorescent CF, as demonstrated by Figure 49. By
encapsulating a fluorescent small molecule during vesicle formation, we were able
to determine if vesicles are forming as expected, and if they are capable of
encapsulating small molecules. These parameters are tested via methods described
in section 2.10.1 and discussed in section 3.8. Overall, all inclusion complexes
formed vesicles and encapsulated the small molecule CF consistently, while
controls did not show any signs of vesicle formation or subsequent encapsulation
of CF.
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Figure 49: Sephadex G-50 column (left) elutes free CF, vesicles, and then smaller
aggregates such as micelles. Fractions 1-3 (right) are bright yellow, orange, and brown
(left-right) where the bright yellow fraction contains free CF, the orange fraction contains
vesicles, and the brown fraction contains smaller aggregates

3.8 Fluorescent Vesicle Encapsulation and Lysing via Fluorimetry
Fluorescent vesicles and controls were prepared according to the methods
described in section 2.9, and discussed in section 3.7. Fluorescence spectroscopy
was ran according to the methods described in section 2.10.1 to probe the behavior
of the vesicles to see if they formed and encapsulated fluorescent probe CF as
expected. This method relies on the principles of the quenching of fluorescence,
which is a process in which a fluorophore comes into contact with a quencher by
either a static or dynamic mechanism to effectively decrease the fluorescence
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intensity of a sample.77 In the case of CF, it acts as both the fluorophore and the
quencher through a static mechanism as it forms non-fluorescent dimers with itself
at high concentrations.78 For these experiments, CF was encapsulated in the interior
of supramolecular vesicles at a concentration of 50 mM, which is well above the
self-quenching concentration.78 Therefore, when encapsulated in the vesicles, CF
is non-fluorescent. When the vesicles are lysed, encapsulated CF is released to the
surrounding environment and substantially diluted with regain of fluorescence.
This process was monitored via fluorescence spectroscopy with diluted
vesicle samples, so if vesicles formed and encapsulated CF a large change in the
fluorescence intensity is observed when lysed with 10% Triton X-100 detergent. If
vesicles did not form, a small change in fluorescence intensity is observed when
lysed with 10% Triton X-100 as a result of the dilution of any free CF already in
solution, or the breaking up of other aggregates that may contain small amounts of
CF. As demonstrated by Figure 50, all inclusion complex samples demonstrate a
large increase in fluorescence compared to controls (ie. host and guest molecules
on their own).
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Figure 50: Initial vesicle lysing %∆Fluorescence Intensity (left) of inclusion complexes
βCD-C12:AdSSPEGOMe, βCD-C12:AdSSPEG, βCD-C14:AdSSPEGOMe, and βCDC14:AdSSPEG and controls AdSSPEGOMe, AdSSPEG, βCD-C12, and βCD-C14 shows
a much higher average %∆Fluorescence Intensity for inclusion complex samples (ie.
vesicles) than it does for controls (ie. host and guest molecules on their own), which
indicates vesicle formation and CF encapsulation for inclusion complexes, while controls
do not form vesicles or encapsulate CF. Two-week vesicle lysing %∆Fluorescence
Intensity (right) shows the same average %∆Fluorescence Intensity for inclusion complex
samples (ie. lysed vesicles) and controls, which indicates that the vesicles formed from
inclusion complex samples have self-degraded
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Figure 51: AdSSPEGOMe:𝛽CD-C12 inclusion complex formed vesicles with encapsulated

CF. When lysed with 250 𝜇L 10% Triton X-100 there is a large increase in fluorescence
intensity because CF is released and diluted below the self-quenching concentration range

These unique properties of the host and guest molecules confirm that the
supramolecular amphiphiles are formed, self-assemble into vesicles, and
encapsulate CF, while controls do not form vesicles on their own. All samples were
measured over time to monitor self-degradation behavior, and it was found that the
vesicles degraded on their own after approximately two weeks, as evident by the
uniform increase in fluorescence compared to controls. All measurements used to
calculate average values shown in Figure 50 are listed in Table 3, and a sample raw
fluorescence measurement is demonstrated by Figure 51 (all other fluorescence
measurements can be found in the appendix).
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Table 3: % ∆Fluorescence Intensity of vesicle forming inclusion complexes with
encapsulated CF, and controls when lysed with 250 𝜇L 10% Triton X-100 over time. After
two weeks, the vesicles with encapsulated CF have degraded, which is evident by the
decrease in % ∆Fluorescence Intensity compared to previous measurements

Time

Initial

1 week

2 week

Sample
AdSSPEG1000
𝛽CD-C12
𝛽CD-C14
AdSSPEGOMe1000
AdSSPEG1000: 𝛽CD-C12
AdSSPEG1000: 𝛽CD-C14
AdSSPEG1000OMe: 𝛽CD-C12
AdSSPEG1000OMe: 𝛽CD-C14
AdSSPEG1000
𝛽CD-C12
𝛽CD-C14
AdSSPEGOMe1000
AdSSPEG1000: 𝛽CD-C12
AdSSPEG1000: 𝛽CD-C14
AdSSPEG1000OMe: 𝛽CD-C12
AdSSPEG1000OMe: 𝛽CD-C14
AdSSPEG1000
𝛽CD-C12
𝛽CD-C14
AdSSPEGOMe1000
AdSSPEG1000: 𝛽CD-C12
AdSSPEG1000: 𝛽CD-C14
AdSSPEG1000OMe: 𝛽CD-C12
AdSSPEG1000OMe: 𝛽CD-C14

% ∆Fluorescence
Intensity
328.57
209.52
369.70
96.08
2071.43
1768.42
2203.03
1875.00
254.17
150.88
272.55
135.29
2070.00
1548.15
2185.71
1821.05
409.68
267.65
248.57
110.00
156.41
156.76
408.57
175.00

3.9 Vesicle Particle Size via DLS
Samples that were demonstrated to form vesicles, as discussed in section
3.8, (ie. inclusion complexes βCD-C12:AdSSPEGOMe, βCD-C12:AdSSPEG,
βCD-C14:AdSSPEGOMe, and βCD-C14:AdSSPEG) were prepared via the
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method described in section 2.8, and initially discussed in section 3.6, for
measuring particle size via DLS.

Table 4: Particle size of vesicle samples comparing isolation methods of probe sonication
and extrusion, wherein extrusion yields more consistent hydrodynamic radii and lowers
polydispersity

Sample

AdSSPEG1000: 𝛃CD-C12

AdSSPEG1000: 𝛃CD-C14

AdSSPEGOMe1000: 𝛃CDC12
AdSSPEGOMe1000: 𝛃CDC14

Isolation
Method

# of
peaks

Hydrodynamic
%Intensity*
Radius (nm)*

Probe
Sonication

3

107.13

90.4

58.9

Extruder

2

64.36

98.7

32.3

Probe
Sonication

3

97.53

71.7

52.4

Extruder

3

64.34

94.5

28.2

Probe
Sonication

3

128.43

92.6

98.3

Extruder

2

64.12

93.1

32.4

Probe
Sonication

3

94.23

92.3

23.6

Extruder

2

48.21

93.4

21.2

%PD*

*of the highest intensity peak

As demonstrated by data in Table 4, when comparing vesicle isolation methods of
probe sonication and extrusion, extrusion yields much more consistent
hydrodynamic radii of vesicles (which are consistent with previously mentioned
literature values in section 3.6) with lower polydispersity than probe sonication.
Both of these characteristics are highly desirable for vesicle nanocarriers as their
behavior is more predictable and consistent.
All vesicle containing samples isolated via extrusion were monitored over
the course of ten weeks to determine a time range of when degradation and/or
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further aggregation into much larger particles occurs for vesicles without any
encapsulated payloads. It was previously established that vesicles with
encapsulated CF have a shelf life of approximately two weeks. Here, vesicles
without any encapsulated agent have a shelf life of approximately 3 to 5 weeks.
Interestingly, the particle size distribution of these vesicles became more uniform
over time before degradation/further aggregation occurred, as demonstrated by
Figures 52 and 53. This is likely due to a more stable thermodynamic equilibrium
being established over time after vesicle formation.

Figure 52: Initial % Intensity v. Hydrodynamic Radius (nm) of vesicle samples derived
from inclusion complexes 𝛽CD-C12:AdSSPEGOMe, 𝛽CD-C12:AdSSPEG, 𝛽CDC14:AdSSPEGOMe, and 𝛽CD-C14:AdSSPEG demonstrates uniform radii with low
polydispersity. Note that the legend C12 indicates 𝛽CD-C12 and C14 indicates 𝛽CD-C14
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Figure 53: 1 week % Intensity v. Hydrodynamic Radius (nm) of vesicle samples derived
from inclusion complexes 𝛽CD-C12:AdSSPEGOMe, 𝛽CD-C12:AdSSPEG, 𝛽CDC14:AdSSPEGOMe, and 𝛽CD-C14:AdSSPEG demonstrates even more uniform radii with
lower polydispersity than initial measurements. Note that the legend C12 indicates 𝛽CDC12 and C14 indicates 𝛽CD-C14

3.10 Vesicle Glutathione (GSH) Degradation via DLS
Samples that were demonstrated to form vesicles, as discussed in section
3.8 and 3.9, (ie. inclusion complexes βCD-C12:AdSSPEGOMe, βCDC12:AdSSPEG, βCD-C14:AdSSPEGOMe, and βCD-C14:AdSSPEG) were
prepared via the method described in section 2.8 for measuring vesicle degradation
in the presence of both intracellular and extracellular glutathione (GSH), as well as
10% Triton X-100 via DLS. As previously mentioned in section 1.4.1, GSH is a
naturally occurring antioxidant found at higher concentrations inside cells than
outside. The thiol group in GSH degrades the vesicles through a dynamic disulfide
exchange reaction with the disulfide group embedded in the linear guest molecule
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of the vesicles’ bilayer membrane. This reaction will alter the HLB of the vesicles’
bilayer membrane and cause it to degrade and release any encapsulated payload due
to the degree of polarity and small size of GSH. Hence, GSH was used to mimic
these physiological conditions in vitro. Here, it is desirable for vesicles to degrade
under intracellular concentrations of GSH but remain intact under extracellular
conditions. These experiments were ran according to the method described in
section 2.11.2 with 12 mM GSH to mimic the intracellular environment, and 20
𝜇M GSH to mimic the extracellular environment. Initial vesicle particle size
distributions for these experiments is shown in Figure 53. An aliquot from each
vesicle sample 1 week after formation was incubated overnight in both intra and
extracellular GSH and particle size distribution was measured the next day.
When comparing initial vesicle particle size measurements with vesicle
particle size in 10% Triton X-100 containing environments, all vesicle samples
were reduced to a hydrodynamic radius of approximately 5 nm. This indicates that
all aggregates have been broken up, and is consistent with fluorescent vesicle lysing
results that demonstrate this detergent’s ability to lyse vesicles.
When comparing initial vesicle particle size measurements with vesicle
particle size in GSH containing environments, it can be concluded that there is
much more of a chemical change with the intracellular GSH containing samples
than with the extracellular GSH containing samples. Here, it is evident that the
polydispersity and particle size of the intracellular GSH containing samples
changed dramatically, while the extracellular GSH containing samples still
demonstrate hydrodynamic radii within the expected range for all samples. This
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could indicate that vesicles are more stable in extracellular environments than
intracellular environments, which is ideal for drug delivery systems as it is desirable
for the drug to be released from the vesicle nanocarrier intracellularly and remain
stable extracellularly. Figures 54 and 55 demonstrate this difference in particle size
distribution of vesicles between intracellular and extracellular environments,
respectively, while Figures 56 and 57 demonstrate direct comparisons of vesicle
samples before and after GSH incubation.

Figure 54: 12 mM GSH, pH 8.5, reaction time overnight % Intensity v. Hydrodynamic
Radius (nm)

of

C12:AdSSPEGOMe,

vesicle

samples

derived

𝛽CD-C12:AdSSPEG,

from

inclusion

complexes 𝛽CD-

𝛽CD-C14:AdSSPEGOMe,

and 𝛽CD-

C14:AdSSPEG demonstrates an dramatic increase in polydispersity and a change in overall
particle size, which may indicate vesicle degradation in intracellular environments. Note
that the legend C12 indicates 𝛽CD-C12 and C14 indicates 𝛽CD-C14
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Figure 55: 20 µM GSH, pH 8.5, reaction time overnight % Intensity v. Hydrodynamic
Radius

(nm)

of

C12:AdSSPEGOMe,

vesicle

samples

derived

βCD-C12:AdSSPEG,

from

inclusion

complexes βCD-

βCD-C14:AdSSPEGOMe,

and

βCD-

C14:AdSSPEG demonstrates a slight increase in polydispersity, but no change in overall
particle size, which may indicate vesicle stability in extracellular environments. Note that
the legend C12 indicates βCD-C12 and C14 indicates βCD-C14

For intracellular GSH containing samples, new peaks at less than 1 nm and greater
than 1000 nm in radii are observed. This could indicate that the vesicles are either
being broken down into smaller aggregates such as micelles or the individual
inclusion complex building blocks (ie. less than 1 nm), or are forming even larger
aggregates (ie. greater than 1000 nm) once the highly ordered vesicle structure is
destroyed by intracellular GSH. This is because, contrary to 10% Triton X-100,
GSH will only disrupt vesicles, while the detergent disrupts all aggregates.
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Figure 56: 12 mM GSH, pH 8.5, reaction time overnight compared to initial % Intensity
v. Hydrodynamic Radius (nm) of vesicle samples derived from inclusion complex 𝛽CDC12:AdSSPEGOMe demonstrate a dramatic increase in polydispersity and a very wide
broadening of overall particle size distribution, which may indicate vesicle degradation in
intracellular environments. Note that the legend C12 indicates 𝛽CD-C12
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Figure 57: 20 𝜇M GSH, pH 8.5, reaction time overnight compared to initial % Intensity
v. Hydrodynamic Radius (nm) of vesicle samples derived from inclusion complex 𝛽CDC14:AdSSPEGOMe demonstrate an increase in polydispersity and a slight broadening of
overall particle size distribution, which may indicate vesicle stability in extracellular
environments. Note that the legend C14 indicates 𝛽CD-C14

It is important to note that these experiments only indicate whether or not a
reaction is happening with GSH in extracellular and intracellular environments, and
does not definitively confirm, but rather may indicate, whether or not vesicles are
degrading. This is because DLS only measures hydrodynamic radius, which is by
definition dynamic, and may change as a result of external environment with or
without vesicle degradation. Dialysis experiments that measure the concentration
of encapsulated payload release over time are currently underway to determine
definitively if vesicles are degrading in extracellular or intracellular environments
or not, as well as the rate of release of encapsulated drugs.
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3.11 Hydrogel Formation
Hydrogel formation was attempted with each vesicle sample that was
demonstrated to form vesicles, as discussed in section 3.8-3.10, (ie. inclusion
complexes

βCD-C12:AdSSPEGOMe,

βCD-C12:AdSSPEG,

βCD-

C14:AdSSPEGOMe, and βCD-C14:AdSSPEG). As previously mentioned in
section 1.5.1, it is desirable to combine vesicle and hydrogel drug delivery
platforms to mitigate their individual drawbacks (ie. burst release of encapsulated
drug with hydrogels, and poor stability of vesicles), and create an optimized hybrid
drug delivery system. Here, vesicles were prepared via the method described in
section 2.8, and hydrogel gelation reactions were attempted via the method
described in section 2.12. Although a variety of pHs (7.4, 8.5), temperatures (25,
30, 35, 40, 45, 50, 55 ℃), and amounts of PEGdiSH [7a-f] and vesicles were tested,
all samples demonstrated liquid flow behavior and were not able to hold their own
weight, which is not consistent with hydrogel formation. Samples with PEGdiSH
[7e, 7f] molecular weight of 10000 or 20000 g/mol demonstrated a visual increase
in viscosity at pH 8.5 and all temperatures and ≥ 10 wt/wt% PEGdiSH, which
indicates that a reaction is occurring.
In theory, the disulfide exchange between the thiol group in the hydrophilic
crosslinker (PEGdiSH) and the disulfide group in the vesicles should not lyse the
vesicles, as the exterior HLB is maintained with a hydrophilic crosslinker. This
theory was confirmed via DLS particle size measurements (ran according to the
method described in section 2.11.1) with the PEGdiSH [7e] containing vesicle
solutions (20 wt/wt% PEGdiSH calculated according to Equation 4, pH 8.5,
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reaction time 1 hr at room temperature). Particle size distribution demonstrated by
Figures 58 indicate that the vesicles are stable with crosslinker addition, as the
particle size was only slightly increased, and polydispersity was shown to be
unchanged compared to initial measurements demonstrated by Figure 53. Figure
59 shows a direct comparison between a neat vesicle sample, and a PEGdiSH
containing vesicle sample which confirm the aforementioned observations.
Additionally, it is evident that a reaction is occurring and eliciting a chemical
change in the solution by the slight increase in particle size, but this reaction was
not enough to crosslink the vesicles into a hydrogel.

Figure 58: 20 wt/wt% PEGdiSH [7e], pH 8.5, reaction time 1 hour % Intensity v.
Hydrodynamic Radius (nm) of vesicle samples derived from inclusion complexes 𝛽CDC12:AdSSPEGOMe,

𝛽CD-C12:AdSSPEG,

𝛽CD-C14:AdSSPEGOMe,

and 𝛽CD-

C14:AdSSPEG demonstrates no change in polydispersity, and a slight increase in overall
particle size, which may indicate vesicle stability with a hydrophilic crosslinker. Note that
the legend C12 indicates 𝛽CD-C12 and C14 indicates 𝛽CD-C14, and PEGdiSH10k
indicates [7e]
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Figure 59: 20 wt/wt% PEGdiSH [7e], pH 8.5, reaction time 1 hour % Intensity v.
Hydrodynamic Radius (nm) of vesicle samples derived from inclusion complexes 𝛽CDC12:AdSSPEGOMe demonstrates no change in polydispersity, and a slight increase in
overall particle size, which may indicate vesicle stability with a hydrophilic crosslinker.
Note that the legend C12 indicates 𝛽CD-C12 and PEGdiSH10k indicates [7e]

Results from previous experiments testing vesicle stability in intracellular
and extracellular GSH environments (discussed in section 3.10) indicate that the
disulfide bond embedded in the exterior of the vesicle membrane is indeed
accessible, as some vesicle degradation was indicated in intracellular GSH
environments. Hence, it can be further confirmed that a reaction is happening, but
that the overall crosslinking density is not enough to form a hydrogel. Future
experiments with multi-arm PEGdiSH crosslinkers would likely increase the
crosslinking density enough to form a hydrogel.
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4. CONCLUSION
In summary, thioalkyl modified 𝛽CD-C12 [2a] and 𝛽CD-C14 [2b] were
successfully synthesized as macrocyclic hosts for novel AdSSPEGOMe [5b] and
AdSSPEG [5a] linear guest molecules. All host and guest combinations were
demonstrated to form inclusion complexes with critical aggregation concentrations
in the range of 30-40 𝜇M. These inclusion complexes were used to form bilayered
vesicles with hydrodynamic diameters ranging from 100-150 nm and were stable
for over a month. This shelf life is much longer than is typical of phospholipid
based liposomes of this nature, which indicates enhanced stability from this novel
host: guest combination. All vesicles were also able to encapsulate a small organic
molecule within their core during vesicle formation, with triggered release in the
presence of detergent. Vesicles with a disulfide bond covalent embedded in the
bilayer membrane were shown to be more sensitive to intracellular concentrations
of GSH than extracellular through a dynamic disulfide exchange reaction, which
could serve as a stimuli induced release mechanism for encapsulated payloads once
vesicles are taken up into cells.
Linear PEGdiSH [7a-f] of varying molecular weights from 1000-20000
g/mol were also successfully synthesized as crosslinking molecules to link the
three-dimensional vesicles as multivalent junctions and form a hydrogel coating.
However, although a variety of pHs, temperatures, and ratios of SH/SS were tested,
hydrogels did not form under any conditions. A visual increase in viscosity was
observed with crosslinkers with molecular weights ≥ 10000 g/mol, so there was
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evidence that a reaction was occurring. It can be concluded that the crosslinking
density with the linear crosslinkers was not enough to form a hydrogel.
Overall, vesicles formed from this novel host: guest combination are
extremely promising for achieving a hybrid vesicle-hydrogel drug delivery system
that can be applied as a coating or injected directly to a target site. The
biocompatibility, stimuli responsivity, enhanced stability, and ease of preparation
and modification of these materials is highly desirable for this purpose. Future work
is needed to bring this novel drug delivery system from in vitro studies to in vivo
studies for commercial applicability.
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5. FUTURE WORK
Future work on this project should include more quantitative release studies
with all vesicle samples. These studies should include the use of a model drug
molecule such as curcumin, 𝛼-tocopherol, or doxorubicin. Vesicles with
encapsulated drug payload should be isolated so that there is no free drug in
solution, and then treated with both extracellular and intracellular concentrations of
GSH to monitor % Drug Release over time. This method will give information on
the kinetic release rates from these novel vesicles, as well as drug loading capacity
and more quantitative measurements of degradation in the presence of GSH.
Additionally, hydrogel formation studies with a multi-arm thiol terminated
PEG with molecular weight ≥ 10000 g/mol in order to increase the crosslinking
density enough to form a hydrogel should be performed. A 4-arm thiol terminated
PEG with a pentraethythritol core structure, as shown in Figure 60, would be a
suitable material for this purpose.
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Figure 60: Condensed (left) and expanded (left) chemical structures of 4-arm thiol terminated
PEG
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Once hydrogels are formed, they should be characterized for mechanical and
rheological properties, as well as swelling behavior and adhesion to various
materials commonly used in medical devices. The crosslinking molecule should
then be modified with an acid labile siyl-ether bond in its core structure to embed
an acid sensitive degradation mechanism. Hydrogels, similarly to the vesicles,
should also be studied for the encapsulation and release of model drugs with
environments of varying acidity to probe the triggered degradation, drug loading
capacity, and release rates of the material.
It may also be of interest to modify the host and guest molecules with
varying functionalities to probe their behavior for other drug delivery related
applications. All suggestions for future work are summarized in Figure 61.
Additionally, once all future work pathways described in Figure 61 have
been explored, this material should undergo additional multidisciplinary
characterizations by biologists and/or biomedical engineers to determine the
viability of this novel drug delivery system for commercial applications as
antibacterial coatings. Among others, these studies should include in vitro cell
viability and drug delivery tests under physiological conditions, as well as broad
spectrum bactericidal studies with encapsulated antibiotics to determine their safety
in the presence of healthy eukaryotic cells versus bacteria-infected cells, as well as
their effectiveness against a variety of different types of bacteria, respectively. Once
in vitro studies have been thoroughly explored and the material has been further
optimized to demonstrate viability, in vivo studies should be conducted according
to FDA standards.
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Figure 61: Summary of future work includes a) functionalization of vesicles b) crosslinking to
form a hydrogel with thiol terminated 4-arm PEG with a siyl-ether core structure c) acid
triggered degradation and release of hydrogel encapsulated payload and d) GSH triggered
degradation and release of vesicle encapsulated payload
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APPENDICES
A. Supporting Information

Figure 1A: 1H NMR of PEGdiSH (n = 22 [7a], 1000 g/mol) in deuterated chloroform (CDCl3)
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Figure 2A: 1H NMR of PEGdiSH (n = 45 [7b], 2000 g/mol) in deuterated chloroform (CDCl3)
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Figure 3A: 1H NMR of PEGdiSH (n = 77 [7c], 3400 g/mol) in deuterated chloroform (CDCl3)

*Note- 1H NMR for PEGdiSH (n = 90 [7d], 4000 g/mol) can be found on page 89
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Figure 4A: 1H NMR of PEGdiSH (n = 227 [7e], 10000 g/mol) in deuterated chloroform (CDCl3)
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Figure 5A: 1H NMR of PEGdiSH (n = 454 [7f], 20000 g/mol) in deuterated chloroform (CDCl3)
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Table 1A: AdSSPEGOMe fluorescence measurements with varying concentration of amphiphile
and 0.156 𝜇𝑔/𝑚𝐿 nile red
[Amphiphile]
(µM)
60

80

100

120

140

160

180

200

300

400

500

Avg 𝝀𝒆𝒎 𝒎𝒂𝒙
(nm)

Avg Intensity
(CPS)

618

Intensity
(CPS)
1916830

2

617

1833120

618

1867717

3

619

1853200

1

616

2497720

2

618

1919240

617

2284580

3

616

2436780

1

611

2622970

2

616

2487530

613

2563893

3

612

2581180

1

605

3231220

2

611

3078210

609

3137913

3

611

3104310

1

613

3280050

2

611

3274040

611

3257833

3

610

3219410

1

608

3538580

2

608

3516570

608

3514243

3

609

3487580

1

606

3769400

2

609

3513960

606

3625443

3

603

3592970

1

606

3879300

2

609

3938560

609

3904533

3

612

3895740

1

611

3756220

2

612

3667560

612

3676017

3

612

3604270

1

610

3899340

2

611

3866450

611

3892133

3

611

3910610

1

613

4212220

2

612

4196020

612

4203663

3

612

4202750

Trial #

𝝀𝒆𝒎 𝒎𝒂𝒙 (nm)

1

143

Table 2A: AdSSPEG:𝛽CD-C12 fluorescence measurements with varying concentration of
amphiphile and 0.156 𝜇𝑔/𝑚𝐿 nile red
[Amphiphile]
(𝝁𝑴)
20

25

30

35

40

45

50

55

60

80

100

Trial #

𝝀𝒆𝒎 𝒎𝒂𝒙 (nm)

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

589
583
582
592
588
586
592
585
588
596
598
597
605
608
610
594
592
598
620
623
625
623
623
630
622
627
625
629
629
628
632
635
636
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Intensity
(CPS)
2692380
2495070
2424230
3132520
3195730
3126270
3365420
3353890
3324520
3471490
3433940
3403110
3802830
3885400
3857540
3928990
3978470
3943880
4194430
4192320
4196380
4196350
4199820
4199210
4203100
4195670
4195830
4191630
4196600
4198350
4196930
4195210
4197790

Avg 𝝀𝒆𝒎 𝒎𝒂𝒙
(nm)

Avg Intensity
(CPS)

585

2537227

589

3151507

588

3347943

597

3436180

608

3848590

595

3950447

623

4194377

625

4198460

625

4198200

629

4195527

634

4196643

Table 3A: AdSSPEG:𝛽CD-C14 fluorescence measurements with varying concentration of
amphiphile and 0.156 𝜇𝑔/𝑚𝐿 nile red
[Amphiphile]
(𝝁𝑴)
15

20

25

30

35

40

45

50

55

60

80

100

Trial #

𝝀𝒆𝒎 𝒎𝒂𝒙 (nm)

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

596
599
594
599
598
585
600
595
600
606
609
607
610
614
609
611
619
615
626
628
630
629
631
625
632
630
630
628
629
625
630
632
626
628
626
632
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Intensity
(CPS)
1773950
1816450
1841390
2330300
2314230
2227960
2683510
2538300
2542010
2673540
2650390
2684720
3187780
3049850
3041560
3219960
3371220
3208380
3454260
3457990
3449620
3457040
3452230
3453180
3455214
3452103
3455330
3455560
3450350
3455940
3454190
3455020
3456880
3456460
3453220
3456140

Avg 𝝀𝒆𝒎 𝒎𝒂𝒙
(nm)

Avg Intensity
(CPS)

596

1810597

594

2290830

598

2587940

607

2669550

611

3093063

615

3266520

628

3453957

628

3454150

631

3454216

627

3453950

629

3455363

629

3455273

Table 4A: AdSSPEGOMe:𝛽CD-C12 fluorescence measurements with varying concentration of
amphiphile and 0.156 𝜇𝑔/𝑚𝐿 nile red
[Amphiphile]
(𝝁𝑴)
10

15

20

25

30

35

40

60

80

100

Trial #

𝝀𝒆𝒎 𝒎𝒂𝒙 (nm)

Intensity (CPS)

1

602

3408420

2

601

3427360

3

602

3330590

1

605

3639430

2

600

3655010

3

598

3595950

1

614

3991630

2

617

3921670

3

612

3930440

1

604

4021960

2

608

4070560

3

608

4037730

1

602

4175370

2

600

4129650

3

607

4104310

1

612

4218940

2

616

4212240

3

615

4210310

1

617

4236910

2

614

4240600

3

615

4243770

1

646

4238920

2

644

4245160

3

643

4245580

1

655

4247980

2

655

4244910

3

655

4235720

1

649

4240510

2

647

4240730

3

647

4242110

Avg 𝝀𝒆𝒎 𝒎𝒂𝒙
(nm)

Avg Intensity
(CPS)

602

3388790

601

3630130

614

3947913

607

4043417

603

4136443

614

4213830

615

4240427

644

4243220

655

4242870

648

4241117

Table 5A: AdSSPEGOMe:𝛽CD-C14 fluorescence measurements with varying concentration of
amphiphile and 0.156 𝜇𝑔/𝑚𝐿 nile red
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[Amphiphile]
(𝝁𝑴)
10

15

20

25

30

35

40

60

80

100

Trial #

𝝀𝒆𝒎 𝒎𝒂𝒙 (nm)

Intensity
(CPS)

1

604

2542740

2

605

2564350

3

606

2642840

1

607

2839610

2

609

2850090

3

605

2852110

1

608

3178680

2

611

3168110

3

611

3110260

1

614

3504140

2

612

3637400

3

611

3530300

1

611

4095710

2

612

4021950

3

611

4085030

1

610

4248320

2

614

4243780

3

611

4253780

1

615

4246680

2

618

4248340

3

616

4249830

1

640

4245970

2

640

4247670

3

641

4243060

1

655

4243540

2

653

4247530

3

652

4243460

1

650

4246240

2

652

4246670

3

648

4242170
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Avg 𝝀𝒆𝒎 𝒎𝒂𝒙
(nm)

Avg
Intensity
(CPS)

605

2583310

607

2847270

610

3152350

612

3557280

611

4067563

612

4248627

616

4248283

640

4245567

653

4244843

650

4245027

Table 6A: Particle size measurements for inclusion complexes and host and guest on their own
prepared by probe sonication vesicle isolation method

Sample

Ratio
(host:guest)

Time
(days)
0

AdSSPEG1000

0 to 1
1
0

AdSSPEG1000OMe

0 to 1
1

0
bCD-C12

1 to 0
1

0
bCD-C14

1 to 0
1
0

AdSSPEG1000/bCD-C12

1 to 1
1
0

AdSSPEG1000/bCD-C14

1 to 1
1

0
AdSSPEg1000OMe/bCD-C12

1 to 1
1

0
AdSSPEG1000OME/bCD- C14

1 to 1
1
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Hydrodynamic
Radius (nm)
1.522
95.123
0.706
11.236
6.28
106.642
6.03
42.443
187.776
7.097
88.23
1189.18
19018.2
6.827
93.824
503.546
3.912
9.791
73.922
384.427
3.689
161.629
1.704
107.131
934.781
2.239
113.813
1.648
97.53
518.176
2.747
33.446
112.225
1333.97
6.291
128.431
14920.5
3.247
39.506
222.854
5.059
94.234
535.093
6.1
119.979

%Intensity

%PD

2.1
97.9
2.1
2.2
0.9
99.1
5.1
60.9
34
2.8
76
18.1
3.1
1.6
54.3
44
0.7
0.7
64.7
33.9
1
93.5
2.3
90.4
7.3
1.6
98.4
1.8
71.7
26.5
1.4
9
81.7
7.9
4.2
92.6
3.2
1.9
34.5
63.7
2
92.3
5.7
1.4
98.6

40.6
44.2
18.6
15.7
10.8
106.8
8.8
17.6
16.8
11.9
36.3
56.2
43.8
11.5
11.7
12.1
0
7.9
21.8
16.3
9.9
85.2
12.8
58.9
30.5
19.7
66.1
13.8
52.4
43.9
11.9
17.3
29.1
20.5
0
98.3
57.1
11.8
37.2
47.5
6.9
23.6
19
7.9
18.5

Table 7A: Particle size measurements for inclusion complexes and host and guest on their own
prepared by extrusion vesicle isolation method
Sample

Ratio
(host:guest)

Time
(days)
0

AdSSPEG1000

0 to 1
1

0
AdSSPEG1000OMe

0 to 1
1
0

bCD-C12

1 to 0
1

0
bCD-C14

1 to 0
1
0

AdSSPEG1000:bCD-C12

1 to 1
1
0

AdSSPEG1000:bCD-C14

1 to 1
1
0

AdSSPEg1000OMe:bCD-C12

1 to 1
1
0

AdSSPEG1000OMe:bCD- C14

1 to 1
1
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Hydrodynamic
Radius (nm)
0.569
5.383
70.162
5.472
67.59
296.919
3.458
20.406
71.553
11.236
59.84
4.29
67.057
1.724
8.475
62.095
430.904
1.397
98.248
817.548
1.929
88.27
1300.87
5.026
64.357
3.5
95.98
1.016
13.692
64.336
1.349
69.188
9.19
64.121
7.803
61.905
5.814
48.21
6.515
51.361

%Intensity

%PD

0.2
0.7
99.2
1
86.9
12.1
2.5
18.8
78.7
11.8
88.2
0.7
99.3
0.1
2
94.9
2.9
0.1
96.2
3.6
1.6
91
7.4
1.3
98.7
12
88
0.7
4.9
94.5
0.7
99.3
6.9
93.1
6.7
93.3
6.6
93.4
7.3
92.7

19.4
15.6
34.4
11.8
27.1
16.8
11.9
16.6
19.7
11.9
24
11.7
39.7
11.8
10.4
12.6
9.3
11
69
29.1
3.8
42.6
70.9
5.2
32.3
11.8
11.9
11.4
15.5
28.2
12.7
48.5
11.5
32.4
6.6
16.8
11
21.2
8.8
22.2

Fluorescence Intensity (CPS)

AdSSPEG1000OMe:𝛽CD-C14 (1:1)
830000
630000
430000

10% TritonX-100 added

230000
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80

Time (s)
Figure 6A: Initial lysing of AdSSPEGOMe:βCD-C14 inclusion complex measured via fluorescence
spectroscopy.. When lysed with 250 µL 10% Triton X-100 there is a large increase in fluorescence
intensity which indicates vesicles formed with encapsulated CF
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820000
620000
420000

10% TritonX-100 added
220000
20000
0

10

20

30

40

50

60

70

80

90

Time (s)
Figure 7A: Initial lysing of AdSSPEG:βCD-C14 inclusion complex measured via fluorescence
spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a large increase in fluorescence
intensity which indicates vesicles formed with encapsulated CF

*Note – AdSSPEGOMe: βCD-C12 initial lysing measurements can be found on page 106
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Figure 8A: Initial lysing of AdSSPEG:βCD-C12 inclusion complex measured via fluorescence
spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a large increase in fluorescence
intensity which indicates vesicles formed with encapsulated CF
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Figure 9A: Initial lysing of AdSSPEGOMe guest measured via fluorescence spectroscopy. When
lysed with 250 µL 10% Triton X-100 there is a small increase in fluorescence intensity which
indicates vesicles did not form
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Figure 10A: Initial lysing of AdSSPEG guest measured via fluorescence spectroscopy. When lysed
with 250 µL 10% Triton X-100 there is a small increase in fluorescence intensity which indicates
vesicles did not form
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Figure 11A: Initial lysing of βCD-C12 host measured via fluorescence spectroscopy. When lysed
with 250 µL 10% Triton X-100 there is a small increase in fluorescence intensity which indicates
vesicles did not form
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Figure 12A: Initial lysing of βCD-C14 host measured via fluorescence spectroscopy. When lysed
with 250 µL 10% Triton X-100 there is a small increase in fluorescence intensity which indicates
vesicles did not form
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Figure 13A: 1 week lysing of AdSSPEGOMe:βCD-C14 inclusion complex measured via
fluorescence spectroscopy is consistent with initial measurements
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Figure 14A: 1 week lysing of AdSSPEGOMe:βCD-C12 inclusion complex measured via
fluorescence spectroscopy is consistent with initial measurements
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Figure 15A: 1 week lysing of AdSSPEG:βCD-C12 inclusion complex measured via fluorescence
spectroscopy is consistent with initial measurements
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Figure 16A: 1 week lysing of AdSSPEG:βCD-C14 inclusion complex measured via fluorescence
spectroscopy is consistent with initial measurements
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Figure 17A: 1 week lysing of AdSSPEGOMe guest measured via fluorescence spectroscopy is
consistent with initial measurements
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Figure 18A: 1 week lysing of AdSSPEG guest measured via fluorescence spectroscopy is consistent
with initial measurements
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Figure 19A: 1 week lysing of βCD-C12 host measured via fluorescence spectroscopy is consistent
with initial measurements
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Figure 20A: 1 week lysing of βCD-C14 host measured via fluorescence spectroscopy is consistent
with initial measurements
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Figure 21A: 2 week lysing of AdSSPEGOMe:βCD-C14

inclusion complex measured via

fluorescence spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a small increase in
fluorescence intensity which indicates vesicles have degraded
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Figure 22A: 2 week lysing of AdSSPEGOMe:βCD-C12

inclusion complex measured via

fluorescence spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a small increase in
fluorescence intensity which indicates vesicles have degraded
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Figure 23A: 2 week lysing of AdSSPEG:βCD-C12 inclusion complex measured via fluorescence
spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a small increase in fluorescence
intensity which indicates vesicles have degraded
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Figure 24A: 2 week lysing of AdSSPEG:βCD-C14 inclusion complex measured via fluorescence
spectroscopy. When lysed with 250 µL 10% Triton X-100 there is a small increase in fluorescence
intensity which indicates vesicles have degraded
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Figure 25A: 2 week lysing of AdSSPEG guest measured via fluorescence spectroscopy is consistent
with initial measurements
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Figure 26A: 2 week lysing of AdSSPEGOMe guest measured via fluorescence spectroscopy is
consistent with initial measurements
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Figure 27A: 2 week lysing of βCD-C12 host measured via fluorescence spectroscopy is consistent
with initial measurements
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Figure 28A: 2 week lysing of βCD-C14 host measured via fluorescence spectroscopy is consistent
with initial measurements

Table 8A: Particle size measurements of vesicles treated with 12 mM GSH to mimic intracellular
environments
Sample

Ratio
(host:guest)

Time Since GSH
Added
before

AdSSPEG1000:𝛃CD-C12

1 to 1
overnight
before

AdSSPEG1000:𝛃CD-C14

1 to 1
overnight
before

AdSSPEg1000OMe:𝛃CD-C12

1 to 1
overnight
before

AdSSPEG1000OMe:𝛃CD- C14

1 to 1
overnight
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Hydrodynamic
Radius (nm)
5.026
64.357
0.589
1159.24
1.016
13.692
64.336
0.618
153.649
9.19
64.121
2.432
22.242
77.074
495.931
5.814
48.21
0.604
56.458
905.557

%Intensity

%PD

1.3
98.7
16
84
0.7
4.9
94.5
63.8
36.2
6.9
93.1
0.7
24.8
69.8
4.7
6.6
93.4
5.3
92.6
2.2

5.2
32.3
55.2
330.7
11.4
15.5
28.2
41.4
67
11.5
32.4
0
11.3
18.7
8.1
11
21.2
36.6
87
34.3

Table 9A: Particle size measurements of vesicles treated with 20 𝜇M GSH to mimic extracellular
environments
Sample

Ratio
(host:guest)

Time Since GSH
Added
before

AdSSPEG1000: 𝛃CD-C12

1 to 1
overnight

before
AdSSPEG1000: 𝛃CD-C14

1 to 1
overnight

AdSSPEG1000OMe: 𝛃CDC12

AdSSPEG1000OMe: 𝛃CDC14

before
1 to 1
overnight
before
1 to 1
overnight
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Hydrodynamic
Radius (nm)
5.026

%Intensity

%PD

1.3

5.2

64.357

98.7

32.3

0.512

0.9

21.7

95.004

99.1

57.3

1.016

0.7

11.4

13.692

4.9

15.5

64.336

94.5

28.2

1.902

9.4

44.3

59.337

90.6

38.4

9.19

6.9

11.5

64.121

93.1

32.4

4.563

1.3

11.2

62.883

98.7

46.3

5.814

6.6

11

48.21

93.4

21.2

6.09

2.4

20.4

57.139

97.6

46.3

Table 10A: Particle size measurements of vesicles and PEGdiSH crosslinker [7e] with a molecular
weight of 10000 g/mol

Sample

Ratio
(host:guest)

Mol
Ratio
SH/SS

SH %
wt

Time Since
Crosslinker
Added
before

AdSSPEG1000:𝛃CD-C12

1 to 1

1 to 1

20
overnight

before
AdSSPEG1000:𝛃CD-C14

1 to 1

1 to 1

20
overnight

AdSSPEg1000OMe:𝛃CDC12

before
1 to 1

1 to 1

20
overnight
before

AdSSPEG1000OMe:𝛃CDC14

1 to 1

1 to 1

20
overnight
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Hydrodynamic
Radius (nm)

%Intensity

%PD

5.026
64.357
7.43
35.243
99.55
1.016
13.692
64.336
9.56
72.737
9.19
64.121
3.496
107.038
5.814
48.21
1.487
144.648
3304.26

1.3
98.7
3.2
9.3
87.4
0.7
4.9
94.5
8
92
6.9
93.1
1.7
98.3
6.6
93.4
4.6
85
10.4

5.2
32.3
10.6
16.2
25.5
11.4
15.5
28.2
9.8
19
11.5
32.4
11.8
9.7
11
21.2
5.8
16.2
25.4

